fructosamine has been researched along with Diabetes Mellitus, Adult-Onset in 373 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 37 (9.92) | 18.7374 |
| 1990's | 143 (38.34) | 18.2507 |
| 2000's | 102 (27.35) | 29.6817 |
| 2010's | 69 (18.50) | 24.3611 |
| 2020's | 22 (5.90) | 2.80 |
| Authors | Studies |
|---|---|
| Almdal, T; Bomholt, T; Feldt-Rasmussen, B; Heinrich, NS; Hilsted, L; Hornum, M; Jørgensen, MB; Knop, FK; Larsson, A; Rix, M; Rosthøj, S | 1 |
| Almdal, T; Bomholt, T; Borg, R; Butt, R; Elung-Jensen, T; Feldt-Rasmussen, B; Hornum, M; Knop, FK; Larsson, A; Nørgaard, K; Ranjan, AG; Rix, M; Sarwary, MH | 1 |
| Barroso, I; Butterworth, AS; Danesh, J; Di Angelantonio, E; Riveros-Mckay, F; Roberts, D; Selvin, E; Soranzo, N; Yu, B | 1 |
| Bao, B; Gao, T; Huang, T; Lin, J; Wei, H; Zheng, X; Zhu, H | 1 |
| Carvalho, JAM; Cassol, JPE; Moresco, RN; Scolari, R; Stein, CS | 1 |
| Bannasch, MJ; Delpero, A; Gilor, C; Hulsebosch, SE; Lancaster, T; Murikipudi, S; Pires, J; Ragupathy, R; Zion, T | 1 |
| Baek, HI; Cha, YS; Ha, KC; Kim, DS; Park, SJ | 1 |
| Barko, PC; Laia, NL; McMichael, MA; Reinhart, JM; Sullivan, DR; Williams, DA | 1 |
| Dalpatadu, KPC; Galappatthy, P; Jayasinghe, S; Katulanda, P | 1 |
| Bortolin, RC; Brum, PO; Fonseca Moreira, JC; Gasparotto, J; Gelain, DP; Mautone Gomes, H; Silveira, AK; Terra, SR | 1 |
| Desouza, CV; Fonseca, VA; Kohzuma, T; Rosenstock, J | 1 |
| Ashraf, T; Buckley, AJ; Mohammed Iqbal, C | 1 |
| Colodner, R; Hasanein, J; Hissin, N; Mirsky, N; Nachum, Z; Shwartz, N; Twafra, S; Yefet, E | 1 |
| Iamsaard, S; Yannasithinon, S | 1 |
| Desouza, CV; Fonseca, VA; Frias, JP; Holcomb, RG; Hsia, SH; Klein, EJ; Kohzuma, T; Rosenstock, J; Zhou, R | 1 |
| Bajic, VB; Essack, M; Gluvic, Z; Isenovic, ER; Lackovic, M; Obradovic, M; Samardzic, V; Tica Jevtic, J | 1 |
| Grebhardt, C; Medina Escobar, P; Nydegger, UE; Risch, L; Risch, M; Sakem, B; Stanga, Z | 1 |
| Motala, AA; Nkwanyana, NM; Paruk, IM; Pirie, FJ | 1 |
| Altamash, M; Engstrӧm, PE; Larsson, A; Panezai, J | 1 |
| Araz, M; Aydin, N; Karadağ, G; Kul, S; Tabur, S | 1 |
| Acosta, A; Burton, D; Calderon, G; Camilleri, M; Davis, J; Gedulin, B; Gribble, FM; LaRusso, NF; Linker-Nord, S; McRae, A; Reimann, F; Rievaj, J; Roberts, G; Vella, A; Zandvakili, I | 1 |
| Abdul-Ghani, M; Bergman, M; Bianchi, C; Buysschaert, M; Ceriello, A; Chung, S; Colette, C; Cravalho, C; DeFronzo, RA; Del Prato, S; Dorcely, B; Filipe Raposo, J; Fiorentino, TV; Ibrahim, N; Jagannathan, R; Macedo, MP; Manco, M; Medina, JL; Monnier, L; Monteiro, MP; Neves, JS; Owens, D; Phillips, LS; Rhee, M; Ribeiro, RT; Sesti, G | 1 |
| Baillot-Rudoni, S; Bouillet, B; Brindisi, MC; Duvillard, L; Legris, P; Petit, JM; Rouland, A; Simoneau, I; Vergès, B | 1 |
| Guo, J; Lei, S; Pan, C; Zhou, Y | 1 |
| D'Addio, F; De Salvo, C; Fiorina, P; Gallieni, M; Lunati, ME; Miglio, R; Pastore, I; Rossi, A; Sabiu, G; Zuccotti, GV | 1 |
| Adeyemo, A; Doumatey, AP; Ekoru, K; Feron, H; Rotimi, CN; Zhou, J | 1 |
| Barmpagianni, A; Dalamaga, M; Eleftheriadou, I; Kosta, O; Liatis, S; Makrilakis, K; Tentolouris, A; Tsilingiris, D | 1 |
| Bubulica, MV; Chifiriuc, MC; Ciulu-Costinescu, F; Ionescu-Tîrgovişte, C; Lixandru, D; Mitu, M; Petcu, L; Picu, A; Pîrcălăbioru, GG; Ştefan, S | 1 |
| Kołodziejski, PA; Nowak, KW; Pruszyńska-Oszmałek, E; Strowski, MZ | 1 |
| Aron, D; Colburn, J; Conlin, PR; Pogach, L; Pries, RM; Tschanz, MP | 1 |
| Bourdon, E; Cournot, M; Debussche, X; Guerin-Dubourg, A; Meilhac, O; Planesse, C; Rondeau, P | 1 |
| Baldridge, AS; Boerwinkle, E; Carson, AP; Coresh, J; Duggal, P; Köttgen, A; Li, M; Loomis, SJ; Maruthur, NM; Mei, H; Morrison, A; North, KE; Pankow, JS; Rasmussen-Torvik, LJ; Scharpf, R; Selvin, E | 1 |
| Issad, T; Larger, E; Mostefa-Kara, A; Pagesy, P; Tachet, C | 1 |
| Liu, T; Zhang, L | 1 |
| Kamoshita, S; LE, HT; Nguyen, LT; Nguyen, TH; Shimura, F; Tran, TP; Yamamoto, S | 1 |
| Goswami, K; Kheir, M; Malkani, AL; Parvizi, J; Schwarzkopf, R; Shah, RP; Shohat, N; Tan, TL; Tarabichi, M | 1 |
| Chen, YC; Cheng, HT; Chiang, CK; Chuang, HF; Chueh, SN; Huang, JW; Hung, KY; Lee, SY; Tsai, IC; Wu, HY; Yen, CJ | 1 |
| Baxter, GD; Peplow, PV | 1 |
| Chin, SO; Choi, MC; Chon, S; Fraterrigo, G; Kim, YS; Kwon, MK; Lee, YJ; Oh, S; Pozzilli, P; Rhee, SY; Woo, JT | 1 |
| Anup, MO; Aparna, K; Biswas, S; Dandu, A; Gowda, N; Jagannath, MR; Lakshmi, MN; Moolemath, Y; Raghav, V; Reddy, A; Sadasivuni, M; Shilpa, PC; Singh, J; Somesh, BP; Sunil, V; Venkataranganna, MV; Verma, MK | 1 |
| Atkin, SL; Bhandari, S; Cooke, M; Cox, H; Kilpatrick, ES; Konya, J; Lewis, N; Ng, JM | 1 |
| de la Iglesia, S; Herrada, J; Lorenzo-Medina, M; Martín-Alfaro, R; Quintana-Hidalgo, L; Ruiz-García, L | 1 |
| Ciudin, A; Mesa, J; Simó, R; Valladares, S; Zafon, C | 1 |
| Bassett, P; Nayak, AU; Nevill, AM; Singh, BM | 1 |
| Miller, CB; Szwergold, BS | 1 |
| Cohen, JK; Collura, L; Courtney, CL; Herndon, JG; Jones, AC | 1 |
| Choi, JW; Fujii, N; Fujii, T; Lee, JE; Lee, JW | 1 |
| Kurl, S; Laukkanen, JA; Pitocco, D; Ronkainen, K; Zaccardi, F | 1 |
| Fox, RK; Rushakoff, RJ; Shah, AD | 1 |
| Acerini, CL; Craig, ME; de Beaufort, C; Hanas, R; Maahs, DM; Pillay, K; Rewers, MJ | 1 |
| Parrinello, CM; Selvin, E | 1 |
| Grill, V; Gudbjörnsdottir, S; Hammar, N; Jungner, I; Malmström, H; Walldius, G | 1 |
| Wang, Q; Xia, W; Zhang, H; Zhao, Z | 1 |
| Burekovic, A; Dizdarevic-Bostandzic, A; Godinjak, A | 1 |
| Chan, CL; Kelsey, M; Nadeau, KJ; Newnes, L; Pyle, L; Zeitler, PS | 1 |
| Ambery, P; Byerly, R; Dobbins, R; Gaddy, R; Gao, F; Le Monnier de Gouville, AC; Mahar, K; Napolitano, A | 1 |
| Döller, D; Haidinger, M; Hecking, M; Säemann, MD; Sharif, A; Tura, A; Werzowa, J | 1 |
| Frassetto, L; Masharani, U; Nolte Kennedy, M; Schloetter, M; Sebastian, A; Sherchan, P; Stratford, S; Xiao, A | 1 |
| Barberger-Gateau, P; Corvo, L; Gin, H; Gonzalez, C; Grouthier, V; Lorrain, S; Maury, E; Rajaobelina, K; Rigalleau, V; Savel, J | 1 |
| Bertrand, JH; Catargi, B; Douard, H; Feige, JM; Fischbach, M; Iliou, MC; Patois-Vergès, B; Simoneau-Robin, I; Vergès, B | 1 |
| Desouza, CV; Fonseca, VA; Holcomb, RG; Rosenstock, J; Zhou, R | 1 |
| An, N; Ding, Y; Li, J; Li, S; Liu, Z; Lu, H; Wang, T; Wang, Y; Xie, J; Xu, P; Xu, W; Yang, L; Zhang, J; Zhang, Z | 1 |
| Cade, WT; Cahill, AG; Colvin, R; Macones, GA; Tuuli, MG | 1 |
| Islam, MS; Koorbanally, NA; Mohammed, A | 1 |
| Chang, WC; Huang, DW; Shen, SC; Shih, RW; Wu, JS | 1 |
| Artul, S; Habib, G; Hakim, G; Jabaly-Habib, H; Jabbour, A; Khazin, F; Sakas, F | 1 |
| Barbarash, OL; Kagan, ES; Maleva, OV; Mamontova, AS; Tarasova, IV; Trubnikova, OA | 1 |
| Ip, MSM; Lai, AYK; Lam, JCM; Lam, KSL; Tam, TCC; Yuen, MMA | 1 |
| Baumgartner, A; Chan, CL; Kelsey, MM; Nadeau, KJ; Newnes, L; Pyle, L; Zeitler, PS | 1 |
| Edmonds, D; Haggett, M; Robinson, AM; Ruffino, JS; Songsorn, P; Thompson, D; Vollaard, NB | 1 |
| Chabraoui, L; Chebraoui, L; Chraibi, A; El Guessabi, L; Fellat, S; Israili, ZH; Lyoussi, B; M'guil, M; Ragala, MA | 1 |
| Aste, G; Boari, A; Dalessandri, A; Rocconi, F; Vita, S | 1 |
| Cha, JY; Cho, YS; Kim, HS; Kim, YT | 1 |
| Bakiner, O; Bozkirli, E; Demirag, NG; Ertorer, ME; Tutuncu, NB | 1 |
| Chan, YC; Chen, W; Lee, IT; Sheu, WH | 1 |
| Bache, M; Holst, JJ; Højberg, PV; Knop, FK; Krarup, T; Madsbad, S; Rabøl, R; Vilsbøll, T | 1 |
| Haddad, F; Holbrook, I; Jennings, PE; Kalansooriya, A; Whiting, PH | 1 |
| Almdal, T; Boushel, R; Dela, F; Haugaard, SB; Højberg, PM; Madsbad, S; Rabøl, R | 1 |
| Gutschall, MD; Lawrence, FR; Miller, CK; Mitchell, DC | 1 |
| Chinna, K; Gilbertson, H; Kamaruddin, NA; Karim, NA; Talib, RA; Yusof, BN | 1 |
| Alam, K; Ali, A; Ansari, NA | 1 |
| Figenschau, Y; Jorde, R | 1 |
| Bauwens, M; Belmouaz, S; Bridoux, F; Caudwell, V; Charpentier, G; Dardari, D; Franc, S; Hadjadj, S; Marechaud, R; Ragot, S; Riveline, JP; Teynie, J | 1 |
| Cirule, H; Dambrova, M; Grinberga, S; Kalvinsh, I; Kuka, J; Liepinsh, E; Skapare, E; Svalbe, B; Vilskersts, R; Zvejniece, L | 1 |
| Cummings, M; Kar, P; Laight, D; Rooprai, HK; Shaw, KM | 1 |
| Bird, RJ; Dimeski, G; Miller, SP; Pretorius, CJ; Russell, AW; Ungerer, JP | 1 |
| Gul, A; Hasnain, SN; Rahman, MA | 1 |
| Cheng, H; Fu, Z; Li, Y; Ran, J; Shen, J; Wang, M; Xu, L; Yan, L; Zhang, Y | 1 |
| Jenkins, R; Jones, HB; Nugent, D | 1 |
| Elliott, EJ; Thomas, DE | 1 |
| Chong, PP; Idris, F; Low, CF; Mohd Tohit, ER | 1 |
| Avram, MM; Chattopadhyay, J; Desiraju, B; Fazil, I; Jani, CM; Kapupara, H; Mittman, N | 1 |
| Chen, R; Hyatt, T; McCormick, K; Mick, G; Wang, X | 1 |
| Lachin, JM; Nathan, DM; Sacks, DB | 1 |
| Cabezas-Agricola, JM; Camiña, F; Casanueva, FF; Rodríguez, J; Rodríguez-Segade, S | 1 |
| Chanouan, R; Chotchaisuwat, P; Fuangchan, A; Haines, ST; Ingkaninan, K; Plianbangchang, P; Seubnukarn, T; Sirigulsatien, V; Sonthisombat, P | 1 |
| Keers, JC; Kerstens, MN; Kreugel, G; Wolffenbuttel, BH | 1 |
| Azenabor, A; Ogbera, OA; Okeoghene, OA | 1 |
| Akinlade, B; Klasen, S; Kowalski, D; Schwartz, SL; Wilpshaar, W; Zhang, W | 1 |
| Coulter, CV; Duffull, SB; Manning, PJ; Schollum, JB; Vos, FE; Walker, RJ | 1 |
| Ahn, YM; Kang, JS; Kim, SK; Lee, BC | 1 |
| Cao, X; Huang, Z; Li, Y; Liu, J; Liu, L; Wan, X | 1 |
| Panin, LE; Poteryaeva, ON; Russkich, GS | 1 |
| Dungan, KM | 1 |
| Camiña, F; Casanueva, FF; García Lopez, JM; Rodríguez, J; Rodríguez-Segade, S | 1 |
| Amiel, SA; Blumer, IR; Bode, BW; Edelman, SV; Hirsch, IB; Kilpatrick, ES; Seley, JJ; Verderese, CA | 1 |
| Basic, J; Cvetkovic, T; Djordjevic, G; Djordjevic, V; Ljubisavljevic, S; Pavlovic, D; Pavlovic, R; Stojanovic, I; Zabar, K | 1 |
| Banu, I; Charnaux, N; Chen, Q; Chiheb, S; Cosson, E; Cussac-Pillegand, C; Jaber, Y; Nguyen, MT; Valensi, P | 1 |
| Chang, ZY; Chen, HS; Chen, RL; Li, HD | 1 |
| Barcos, M; Berral, FJ; Bravo, D; Escribano, A; Gómez, P; López-Miranda, J; Marín, C; Moreno, JA; Paniagua, JA; Paz-Rojas, E; Pérez-Jiménez, F | 1 |
| Allavoine, T; Howlett, H; Lehert, P; Marre, M | 1 |
| Mafauzy, M | 1 |
| Calle, AP; Diez, MJ; Fernández, N; García, JJ; Sierra, M | 1 |
| Brant, BP; Garvey, WT; Kennedy, A; Rogers, NL; Wallace, P; Willi, SM | 1 |
| Bell-Farrow, AD; Cefalu, WT; Edwards, IJ; Terry, JG | 1 |
| Carter, AW | 1 |
| Khrushcheva, IuV; Mal'tsev, GIu; Popova, IuP; Vasil'ev, AV | 1 |
| Haastert, B; Hauner, H; Lee, YM; Scherbaum, W | 1 |
| Dhindsa, P; Donnelly, R; Scott, AR | 1 |
| Chuang, CK; Clevidence, B; Hosoda, K; Iha, M; Liao, ML; Wang, MF; Yamamoto, S | 1 |
| Baron, AD; Bicsak, TA; Fineman, MS; Gaines, E; Kim, D; Shen, LZ; Taylor, K; Varns, A | 1 |
| Ebinuma, H; Iida, KT; Kawakami, Y; Noguchi, Y; Okuda, Y; Saito, K; Shimano, H; Sone, H; Suzuki, H; Takahashi, A; Toyoshima, H; Ushizawa, K; Yamada, N; Yano, Y | 1 |
| Ali, L; Azad Khan, AK; Faruque, O; Hannan, JM; Mosihuzzaman, M; Nahar, N; Rokeya, B | 1 |
| Bruce, S; Dandona, P; Donovan, DS; Garber, AJ; Park, JS | 1 |
| Khrushcheva, IuV; Mal'tsev, GIu; Popova, IuL; Vasil'ev, AV | 1 |
| Gul, A; Rahman, MA | 1 |
| Muszyńska-Lachota, I | 1 |
| Baillet, L; Gin, H; Rigalleau, V; Roudaut, MF; Vergnot, V | 1 |
| Cwikowska, J; Michno, A; Raszeja-Specht, A; Skibowska, A; Szutowicz, A | 1 |
| Cherian, AM; Cherian, R; John, AJ; Subhash, HS | 1 |
| Chen, HS; Chen, RL; Jap, TS; Lin, HD | 1 |
| Harman-Boehm, I; Hershkovitz, T; Mouritzen, U; Raz, I; Vaz, J; Wainstein, J | 1 |
| Abdel-Gayoum, AG | 1 |
| Cundy, T; Cutfield, WS; Harris, M; Hofman, PL; Hunter, WA; Rabone, D; Regan, F; Robinson, E | 1 |
| Alberca, I; Almeida, M; Burgo, RM; Corrales, JJ; Garca-Berrocal, B; González-Buitrago, JM; Miralles, JM; Orfao, A | 1 |
| Bene, J; Degrell, P; Kószegi, T; Laczy, B; Melegh, B; Molnár, GA; Nagy, J; Tamaskó, M; Wagner, L; Wagner, Z; Wittmann, I | 1 |
| Brown, SJ; Carter, AW; Essary, JL; Greene, D; Lindsey, CC; Mangum, S; McCandless, B; Richardson, A | 1 |
| Bukan, N; Pasaoglu, H; Sancak, B | 1 |
| Kalia, K; Mistry, K; Sharma, S | 1 |
| Allen, E; Conway, MJ; Klaff, LJ; Rosenstock, J; Warren, ML | 1 |
| Camiña, F; Mayan, D; Rodríguez, J; Rodríguez-Segade, S | 1 |
| Morenkova, SA | 1 |
| Halvatsiotis, P; Jaleel, A; Juhasz, P; Martin, S; Nair, KS; Williamson, B | 1 |
| Adams, MB; Kosecki, SM; Rodgers, PT | 1 |
| Duc Son, le NT; Hanh, TT; Hung, NT; Kunii, D; Kusama, K; Sakai, T; Yamamoto, S | 1 |
| Andersen, NH; Berg, TJ; Flyvbjerg, A; Hansen, KW; Helleberg, K; Knudsen, ST; Mogensen, CE; Poulsen, PL; Poulsen, SH | 1 |
| Kamarudin, NA; Khalid, BA; Mat, NH; Md Isa, SH; Najihah, I; Nazaimoon, WM; Umar, NA | 1 |
| Krause, R; Lipp, RW; Piswanger, C; Schnedl, WJ; Wallner, SJ | 1 |
| Izkhakov, Y; Niv, E; Vaisman, N | 1 |
| Andersen, NH; Dinesen, DS; Eiskjaer, H; Flyvbjerg, A; Hansen, KW; Helleberg, K; Knudsen, ST; Mogensen, CE; Poulsen, PL; Poulsen, SH | 1 |
| Gotoh, M; Hirooka, Y; Iguchi, A; Li, C; Yatoh, M | 1 |
| Berner, B; Chiang, YK; Cramer, M; Fonseca, V; Lewin, A; Schwartz, S | 1 |
| Ben Rayana, C; Ben Salem, L; Ben Slama, C; Bouguerra, R; El Kadhi, A; Hamzaoui, J; Jabrane, J; Maâtki, C | 1 |
| Azidah, AK; Mafauzy, M; Rosediani, M | 1 |
| Buse, JB; Button, EA; Dungan, KM; Kato, S; Kelly, MM; Largay, J; Wittlin, S | 1 |
| Costa, S; Fermo, I; Galluccio, E; Gatti, R; Lucotti, P; Monti, LD; Piatti, P; Rabaiotti, G; Sandoli, EP; Setola, E | 1 |
| Anaja, PO; Isah, HS; Yahaya, IA | 1 |
| Bayram, F; Cesur, M; Corapcioglu, D; Emral, R; Gonen, S; Gursoy, A; Kamel, N; Ozduman, M; Tonyukuk, V; Uysal, AR; Yilmaz, AE | 1 |
| Kobayashi, A; Nitta, K; Saito, Y; Sugiyama, K | 1 |
| Dijkmans, BA; Nurmohamed, MT; Peters, MJ; Simsek, S; van Deutekom, AW; van Eijk, IC | 1 |
| Bailey, WL; Jones, MR; Kalin, MF; Schwartz, SL; Zieve, FJ | 1 |
| Balabolkin, MI; Filatova, LV; Gorchakova, TV; Nedosugova, LV; Orekhov, AN; Sobenin, IA | 1 |
| Coman, A; Găman, L; Greabu, M; Gruia, V; Mohora, M; Muscurel, C; Vîrgolici, B | 1 |
| Chen, HS; Chen, RL; Jap, TS; Lin, HD; Wu, TE | 1 |
| Carle, F; Di Mauro, M; Fumelli, P; Kosmidis, A; Lazzarini, D | 1 |
| Christopher, R; Covington, P; Davenport, M; Fleck, P; Karim, A; Mekki, QA; Wann, ER | 1 |
| Aoto, H; Hsu, TF; Ito, Y; Kise, M; Kunii, D; Wang, MF; Yamamoto, S; Yang, MD; Yokoyama, J; Yoshihara, R | 1 |
| Clamp, JR; Hartog, M; Hopton, M; Kent, MJ; Light, ND; Paisey, RB | 1 |
| Baker, JR; Johnson, RN; Scott, DJ | 1 |
| Shima, K; Tahara, Y | 1 |
| Close, CF; Holder, R; Lewis, PG; Nattrass, M; Wright, AD | 1 |
| Chow, CC; Cockram, CS; Sorensen, JP; Tsang, LW | 1 |
| Barnett, J; Edelman, S; Herold, DA; Reaven, PD | 1 |
| Mogensen, CE; Nielsen, S; Orskov, H; Schmitz, O | 1 |
| Byks, H; Kaźmierczak, M; Wierusz-Wysocka, B; Wykretowicz, A; Wysocki, H; Zozulińska, D | 1 |
| Karjalainen, A; Linnaluoto, M; Oikarinen, AI; Puukka, R; Ryhänen, L; Salmela, PI; Ukkola, O | 1 |
| Bonetti, G; Buscaglia, P; Fratino, P; Garzaniti, A; Gazzaruso, C; Geroldi, D | 1 |
| Brass, EP; Eckel, RH; Erskine, JM; Gregg, TS; Podlecki, DL; Yost, TJ | 1 |
| Abdella, N; Armstrong, D; Lanham, RJ | 1 |
| Bruce, R; Cundy, T; Rutland, M | 1 |
| Achour, A; Aoun, K; Ben Rayana, MC; Zouaghi, H | 1 |
| Nagai, M; Sakata, K; Shirahama, S; Sueta, H; Tanaka, T; Yanagawa, H | 1 |
| Chan, JC; Cockram, CS; Leung, DH; Nicholls, MG; Tomlinson, B; Yeung, VT | 1 |
| Cardoso-Saldaña, G; Ichazo-Cerro, S; Lerman-Garber, I; Posadas-Romero, C; Zamora-González, J | 1 |
| Brohee, D; Kennes, B; Lefevre, A; Neve, P; Piro, P; Vanhaeverbeek, M | 1 |
| Allegra, A; Buemi, M; Ceruso, D; Corica, F; Cucinotta, D; Di Benedetto, A; Giacobbe, MS; Romano, G | 1 |
| Cathcart, S; Dominiczak, MH; Kilpatrick, ES; Small, M; Stewart, JM | 1 |
| Cervato, G; Cestaro, B; Gandini, R; Gatti, P; Maraffi, F; Megali, R; Montalto, C; Viani, P | 1 |
| Ardawi, MS; Bahnassy, AA; Nasrat, HA | 1 |
| Akhter, J; Islam, N; Kayani, N; Khan, MA | 1 |
| Bagdade, JD; Lane, JT; Otto, ME; Ritter, MC; Subbaiah, PV | 1 |
| Balsano, F; Bellini, C; De Mattia, G; Ferri, C; Laurenti, O; Piccoli, A; Santucci, A | 1 |
| Cundy, T; Koya, H; Mitchell, J; Murphy, C; Roberts, AB | 1 |
| Blickle, JF; Brogard, JM; Gugliucci, A; Menini, T; Sodahlon, YK; Stahl, AJ | 1 |
| Kruseman, AC; Menheere, PP; Müller, PG; Nijst, L; Sels, JP; Wolffenbuttel, BH | 1 |
| Alberti, KG; Klausen, IC; Mogensen, CE; Møller, N; Nielsen, S; Pørksen, N; Schmitz, O | 1 |
| Aideyan, O; Alzaid, A; Nawaz, S | 1 |
| Averbukh, Z; Cohen, N; Cotariu, D; Golik, A; Modai, D; Ramot, Y; Weissgarten, J; Zaidenstein, R | 1 |
| Pfleiderer, S; Rietbrock, N; Wörner, W | 1 |
| Chan, JC; Cockram, CS; Critchley, JA; Tomlinson, B; Walden, RJ | 1 |
| Belkhadir, J; el Ghomari, H; Klöcker, N; Mikou, A; Nasciri, M; Sabri, M | 1 |
| Cuesta, C; Ródenas, S; Sánchez-Cabezudo, M | 1 |
| Crook, MA; Pickup, JC; Tutt, P | 1 |
| Császár, A; Dieplinger, H; Drexel, H; Halmos, T; Juhász, E; Karádi, I; Patsch, JR; Romics, L; Sandholzer, C; Utermann, G | 1 |
| Nagi, DK; Yudkin, JS | 1 |
| Firatli, E; Meric, H; Oz, H; Sivas, A; Unal, T | 1 |
| Ikeda, K; Maezawa, Y; Nakabayashi, T; Toda, G; Toshima, K; Yamauchi, M | 1 |
| Baker, J; Dryson, E; Metcalf, P; Scragg, R | 1 |
| Clemmons, DR; Morrow, LA; Moses, AC; O'Brien, M; Young, SC | 1 |
| Ozben, T; Yegin, A; Yegin, H | 1 |
| Nacitarhan, S; Ozben, T; Tuncer, N | 1 |
| Bucala, R; Founds, HW; Giordano, D; Wolffenbuttel, BH | 1 |
| Dunn, PJ | 1 |
| Bonfigli, AR; Manfrini, S; Marra, M; Piantanelli, L; Pieri, C; Testa, I; Testa, R | 1 |
| Stolba, P; Tvrzická, E; Zák, A; Zeman, M | 1 |
| Bots, ML; Grobbee, DE; Hofman, A; Missov, RM; Pols, HA; Stolk, RP; van der Bom, JG | 1 |
| Johnson, AB; Taylor, R | 1 |
| Dominiczak, MH; Kilpatrick, ES; Small, M | 1 |
| Venekamp, WJ; Westerhuis, LW | 1 |
| Beck-Nielsen, H; Berthezene, F; Boulton, AJ; Donoghue, S; Kumar, S; Lettis, S; Muggeo, M; Persson, B; Spinas, GA; Stewart-Long, P | 1 |
| Ozben, T; Yeğin, A | 1 |
| Fisher, BM; Fraser, WD; Gallacher, SJ; Gemmell, CG; MacCuish, AC; Thomson, G | 1 |
| Hilgertová, J; Hodinár, A; Kvasnicka, J; Skrha, J | 1 |
| Menheere, PP; Nieuwenhuijzen Kruseman, AC; Rondas-Colbers, GJ; Sels, JP; Wolffenbuttel, BH | 1 |
| Beks, PJ; Bertelsmann, FW; Bouter, LM; de Neeling, JN; Heine, RJ | 1 |
| Fukasawa, H; Hotta, N; Kakuta, H; Koh, N; Naruse, K; Sakakibara, F; Takeuchi, N; Yamada, K; Yamada, T | 1 |
| Basu, TK; Basualdo, CG; Wein, EE | 1 |
| Raskin, P; Skillman, CA | 1 |
| Fonseca, VA; Gardner, SF; Granberry, MC; Marx, MA; Skelton, DR; White, LM | 1 |
| Bartek, J; Chlup, R; Ficker, L; Novotny, D; Vaverková, H | 1 |
| Aikens, JE; Aikens, KS; Hunt, S; Wallander, JL | 1 |
| Belniak-Legieć, E; Chmielewska, B; Hasiec, T | 1 |
| Founds, HW; Hepp, KD; Landgraf, R; Mellinghoff, AC; Reininger, AJ; Wuerth, JP | 1 |
| Christiansen, C; Hermansen, K; Pedersen, E; Rasmussen, O; Storm, H; Thomsen, C | 1 |
| Chakraverty, P; Dorrell, L; Hassan, I; Marshall, S; Ong, E | 1 |
| Hammersley, MS; Holman, RR; Manley, SE; Meyer, LC; Morris, RJ; Turner, RC | 1 |
| Arisaka, T; Honda, N; Kawamori, R; Kinoshita, J; Kurahashi, Y; Mochizuki, K; Nakamura, M; Tohjima, T; Watanabe, K; Yamamoto, S; Yoshimoto, T | 1 |
| Aguirre, F; De Paoli, T; Farach, HA; Grinspon, D; Hager, A; Ihlo, J; Martin, I; Poole, CP; Ruiz, M | 1 |
| Balint-Peric, L; Beljic, T; Ginsburg, J; Prelevic, GM | 1 |
| Filipe, P; Freitas, JP; Guerra Rodrigo, F | 1 |
| Barbosa, K; Canguçu, V; Cruz, T; de Lordes Lima, M; Pousada, JC; Rodrigues, LE | 1 |
| Kolterman, OG; Pearson, L; Schoenfeld, SL; Thompson, RG | 1 |
| Ettinger, B; Hom, FG; Lin, MJ | 1 |
| Beck, MO; da Costa, LA; Gross, JL; Silveiro, SP | 1 |
| Bittolo Bon, G; Cazzolato, G; Moro, E; Pais, M; Pianetti, S; Zambon, C | 1 |
| Brooks, B; Molyneaux, L; Ross, G; Yue, DK; Zilkens, R | 1 |
| Elbert, A; Fasulo, V; Ferrari, N; Sanguinetti, SM; Schreier, LE; Wikinski, RL | 1 |
| Chait, A; Clark, S; Hatton, DC; Haynes, RB; Kris-Etherton, P; Maggio, CA; McCarron, DA; McMahon, M; Metz, JA; Morris, CD; Oparil, S; Pi-Sunyer, FX; Resnick, LM; Reusser, ME; Snyder, GW; Stern, JS | 1 |
| David-Dufilho, M; Devynck, MA; Miossec, P; Pariès, J; Valensi, PE; Zkhiri, F | 1 |
| Brighenti, F; Bruce-Thompson, C; Jenkins, DJ; Josse, R; Leiter, LA; Owen, R; Sievenpiper, JL; Spadafora, P; Vidgen, E; Vuksan, V | 1 |
| Kondo, T; Miyakawa, M; Shimada, N; Shirasaya, K; Takahashi, E; Yoshida, K | 1 |
| Goto, Y; Hasegawa, K; Sugiura, Y; Suzuki, H; Yanagimoto, M; Yasuda, Y | 1 |
| Alessandrini, P; Bon, GB; Cazzolato, G; Moro, E; Pais, M; Pianetti, S; Zambon, C | 1 |
| Clauson, P; Damsbo, P; Hatorp, V; Marbury, TC; Müller, PG | 1 |
| Austin, GE; Mullins, RE; Nanes, MS; Rubin, J; Wheaton, R | 1 |
| Kruszynska, YT; Mulford, MI; Olefsky, JM; Yu, JG | 1 |
| Albertini, JP; Attali, JR; Gattegno, L; Lormeau, B; Valensi, P; Vaysse, J | 1 |
| Crook, MA; Hussain, A; Khandhadia, S; Lumb, P; Ridha, A | 1 |
| Gomis, R; Jones, NP; Patwardhan, RN; Squatrito, S; Wolffenbuttel, BH | 1 |
| Cole, ST; Freed, MI; Patwardhan, R; Rappaport, EB; Raskin, P; Yan, Y | 1 |
| Deacon, LF; Jones, NP; Nolan, JJ; Patwardhan, R | 1 |
| Bakir, A; Gill, GV; Hossain, M; Malik, M; Pugh, RN | 1 |
| Contreras, R; Domurat, ES; Dudl, J; Hyatt, JA; Petitti, DB; Ziel, FH | 1 |
| Halwachs-Baumann, G; Krause, R; Krejs, GJ; Lipp, RW; Schnedl, WJ; Trinker, M | 1 |
| Arriaga, S; D'Ottavio, AE; Daniele, SM; Hisano, N; Martínez, SM; Montenegro, SM; Morisoli, L; Picena, JC; Tarrés, MC | 1 |
| Appelbaum, EY; Bar-On, H; Hirshberg, B; Mizrahi, Y; Shapira, MY; Ziv, E | 1 |
| Fatimah, A; Khalid, BA; Osman, A; Ruzita, AT | 1 |
| Chiasera, JM; McCune, SA; Ward-Cook, KM; Wardlaw, GM | 1 |
| Imes, S; Jones, S; Ryan, EA; Wallace, C | 1 |
| Bonfigli, AR; Compagnucci, P; De Grazia, G; Fumelli, D; Manfrini, S; Sirolla, C; Testa, I; Testa, R | 1 |
| Anderson, RJ; Patel, J; Rappaport, EB | 1 |
| Djordjević, PB; Jevtović, T; Kocić, G; Kocić, R; Mikić, D; Pavlović, D; Radenković, S; Stojanović, M | 1 |
| Cunningham, MA | 1 |
| Callahan, P; Deeb, LC; Edelman, SV | 1 |
| Klonoff, DC | 1 |
| Bell-Farrow, AD; Cefalu, WT; King, T; McBride, D; Redmon, E; Wang, ZQ | 1 |
| De Leeuw, IH; Van Acker, KL; Van Gaal, LF | 1 |
| Akanuma, Y; Kawakami, M; Ohashi, Y; Saito, Y; Tanaka, A; Yamada, N | 1 |
| Ademoğlu, E; Gökkusu, C; Palanduz, S; Tamer, S | 1 |
| Narbonne, H; Portugal, H; Pradel, V; Renacco, E; Vialettes, B | 1 |
| Azevedo, MJ; De Mello, V; Gross, JL; Hoefel, A; Leitão, C; Moulin, CC; Paggi, A; Perassolo, M; Zelmanovitz, T | 1 |
| Futami, S; Jinnouchi, S; Kawai, K; Kurose, T; Matsukura, S; Nagamachi, S; Nishii, R; Tamura, S | 1 |
| Bollen, P; Carr, RD; Larsen, MO; Rolin, B; Svendsen, O; Wilken, M | 1 |
| Anderson, RA; Bryden, NA; Bureau, I; Favier, M; Polansky, MM; Roussel, AM | 1 |
| Bruzzo, F; Fiquet, C; Kabir, M; Oppert, JM; Rizkalla, SW; Slama, G; Vidal, H; Wursch, P | 1 |
| Asakawa, A; Inui, A; Kasuga, M; Komatsu, Y; Kotani, K; Nishimura, R; Takao, F; Ueno, N | 1 |
| Emekli, N; Ipbüker, A; Nokay, S; Yarat, A | 1 |
| Da Tos, V; Del Prato, S; Dorella, M; Riccio, A; Vigili de Kreutzenberg, S | 1 |
| Ashwell, SM; Borkman, M; Campbell, LV; Chisholm, DJ | 1 |
| Chan, JC; Cheung, CK; Cockram, CS; Swaminathan, R; Yeung, VT | 1 |
| Mashiba, S; Okuda, S; Tomita, S; Uchida, K | 1 |
| Degenaar, CP; Kruseman, AC; Mercelina, L | 1 |
| Jenkins, AL; Jenkins, DJ; Josse, RG; Vuksan, V; Wolever, TM; Wong, GS | 1 |
| Baker, J; James, A; Roberts, A; Simmons, D | 1 |
| Itakura, M; Kunika, K; Yamashita, K | 2 |
| Bak, JF; Møller, N; Pedersen, O; Saaek, A; Schmitz, O | 1 |
| Grunberger, G | 1 |
| Branchi, A; Fasoli, A; Gandini, R; Maraffi, F; Montalto, C; Rovellini, A; Sommariva, D | 1 |
| Fujii, N; Nobunaga, T; Rikiishi, H; Sagara, M; Satoh, J; Seino, H; Takahashi, K; Tanaka, S; Toyota, T; Zhu, XP | 1 |
| Abadie, RG; Anton, JP; Beddok, RH; Bonneu, M; Buisson, JC; Camaré, R; Clottes, JP; Martini, PF; Soulé-Dupuy, C; Turnin, MC | 1 |
| Dunn, PJ; Jury, DR | 1 |
| Lee, PD; O'Day, MR; Ou, CN; Rognerud, CL; Sherman, LD | 1 |
| Molyneaux, LM; Overland, JE; Willey, KA; Yue, DK | 1 |
| Acosta, M; Bornet, FR; Fontvieille, AM; Penfornis, A; Rizkalla, SW; Slama, G | 1 |
| Buckley, GC; Jenkins, AL; Jenkins, DJ; Josse, RG; Vuksan, V; Wolever, TM; Wong, GS | 1 |
| Castell, C; Figuerola, D; Lloveras, G; Recasens, A | 1 |
| Ismail, F; Khan, N; Lim, TO; Selvan, T; Suppiah, A | 1 |
| Carroccio, A; di Martino, D; Lupo, R; Montalto, G; Notarbartolo, A; Soresi, M | 1 |
| Maezawa, H; Sugiyama, H; Uchimura, I; Watanabe, T | 1 |
| Camiña, MF; Del Río, R; Paz, JM; Rodríguez-Segade, S | 1 |
| al-Muhtaseb, N; al-Yusef, AR; Bajaj, JS | 1 |
| Alberti, KG; Kesteven, P; Laker, MF; Velázquez, E; Winocour, PH | 1 |
| Holman, RR; Steemson, J; Turner, RC | 1 |
| Barnett, AH; Girling, AJ; Gray, L; Le Guen, C; Lunec, J; Sinclair, AJ | 1 |
| Dominiczak, MH; Paterson, JR; Pettigrew, AR; Small, M | 1 |
| Fujishima, M; Iwase, M; Kodama, T; Kurimoto, H; Nakamura, S; Nishitani, H; Nunoi, K; Sato, Y; Yoshizumi, H | 1 |
| Dominiczak, MH; Kilpatrick, ES; MacRury, SM; Paterson, KR | 1 |
| Akanuma, Y; Iwamoto, Y; Kajinuma, H; Kasuga, M; Kosaka, K; Kuzuya, T; Shigeta, Y; Takebe, K; Yamanouchi, T; Yoshida, S | 1 |
| Krantz, S; Lober, M; Lober, S | 2 |
| Chanson, P; Charles, MA; Eschwege, E; Godard, V; Guillausseau, PJ; Lubetzki, J; Paolaggi, F; Peynet, J; Rousselet, F; Timsit, J | 1 |
| Bradley, H; Collier, A; Small, M; Thomson, JA; Wilson, R | 1 |
| Bloom, SR; Requejo, F; Uttenthal, LO | 1 |
| Bloom, SR; Ghatei, MA; Lam, HC; O'Halloran, DJ; Takahashi, K | 1 |
| Taş, S; Zein el Din, RR | 1 |
| Tryggeseth, A | 1 |
| Aw, TC; Ee, CH; Lim, HS | 1 |
| Kaiser, FE; Morley, JE | 1 |
| Baker, J; Metcalf, P; Scragg, R | 1 |
| Drexel, H; Patsch, JR | 1 |
| Henrichs, HR; Lemke, C | 1 |
| Schumann, E; Willms, B | 1 |
| Bosoni, T; Ferrari, E; Fioravanti, M; Melzi d'Eril, GV; Solerte, SB | 1 |
| Henrichs, HR | 1 |
| Brunnbauer, M; Küenburg, E; Müller, MM; Prager, R; Winter, F | 1 |
| Arsenio, L; Baroni, MC; Bodria, P; Bossi, S; Delsignore, R; Ippolito, L; Magnati, G; Mineo, F; Strata, A | 1 |
| al-Mahdi, AM; al-Wali, NM; Atabani, GS; Saeed, BO | 1 |
| Chung, ES; Jhoo, YM; Lee, MH; Lee, SJ; Lee, SS; Lim, SY | 1 |
| Bailey, CJ; Billingham, MS; Hall, RA; Milles, JJ | 1 |
| Bloom, SR; Davis, TM; Massey, H; Proby, C; Scott, R; Strong, JA; Thompson, GR | 1 |
| Bennet, WM; Browning, MC; Fraser, CG; Howey, JE; Jung, RT | 1 |
| Capewell, S; Clarke, BF; Collier, A; Collier, R; Hajducka, C; Matthews, D; Muir, AL | 1 |
| Rustemeijer, C; van Haeften, TW; Walstra, SM | 1 |
| Haji, M; Hashimoto, T; Nawata, H; Sako, Y; Umeda, F | 1 |
| Gea, T; Gómez Reyes, D; Rojas Hidalgo, E | 1 |
| Chellingsworth, MC; Kendall, MJ; Pasi, J; Singh, BM; Wright, AD | 1 |
| Averna, M; Barbagallo, CM; Carroccio, A; Catalano, I; Davì, G; Giovenco, E; Notarbartolo, A; Strano, A | 1 |
| Hay, U; Schernthaner, G | 1 |
| Dorda, W; Hay, U; Müller, MM; Schernthaner, G; Sedlmayer, A | 1 |
| Cubillo, P; Llopis, R | 1 |
| Degenaar, CP; Mercelina, LF; Nieuwenhuijzen Kruseman, AC | 1 |
| Ashby, JP; Frier, BM | 1 |
| Gerbitz, KD; Mayer, R; Schleicher, ED; Wagner, EM | 1 |
| Barnett, AH; Florkowski, CM; Jennings, PE; Jones, AF; Le Guen, C; Lunec, J; O'Donnell, MJ; Richardson, MR | 1 |
| Cefalu, WT; Johnson, CR; Parker, TB | 1 |
| Dominiczak, MH; Macrury, SM; Orrell, JM; Paterson, KR | 1 |
| Al-Hussary, N; Atkins, TW; Beevers, DG; Gill, JS; Pasi, KJ; Zezulka, AV | 1 |
| Degiampietro, P; Hess, T; Peheim, E; Thurnheer, U | 1 |
| Barison, A; Fedele, D; Lapolla, A; Poli, T | 1 |
| Clarke, BF; Howie, AF; Smart, LM; Smith, AF; Walker, SW; Young, RJ | 1 |
| Sayers, A; Tracey, J; Young, B | 1 |
| Dominiczak, MH; McNaught, J; Paterson, KR; Smith, LA | 1 |
| Bird, J; Buckley, G; Giudici, S; Jenkins, AL; Jenkins, DJ; Kalmusky, J; Lam, KY; Patten, RL; Wolever, TM; Wong, GS | 1 |
| Buysschaert, M; Galanti, L; Ketelslegers, JM; Lambert, AE; Mpoy, M; Pirson, F; Pouthier, F | 1 |
| Barnett, AH; Chirico, S; Jennings, PE; Jones, AF; Lunec, J | 1 |
| Baker, J; Cutfield, R; Taylor, W | 1 |
| Banfi, G; Bonini, P; Carenini, A; Carpinelli, A; Ceriotti, F; Mosca, A; Pozza, G; Zoppi, F | 1 |
| Baker, J; Holdaway, I; Reid, I | 1 |
| Cooper, GJ; Scott, DJ | 1 |
| Gan, IE; Moses, RG; San-Gil, F; Schier, GM | 1 |
| Bereczki, Z; Berki, A; Biró, A; Inkei, J; Pátkay, J | 1 |
13 review(s) available for fructosamine and Diabetes Mellitus, Adult-Onset
| Article | Year |
|---|---|
An Expanded Genome-Wide Association Study of Fructosamine Levels Identifies RCN3 as a Replicating Locus and Implicates FCGRT as the Effector Transcript.
Topics: Adult; Atherosclerosis; Calcium-Binding Proteins; Cohort Studies; Diabetes Mellitus, Type 2; Female; Fructosamine; Gene Expression Regulation; Gene Frequency; Genetic Loci; Genetic Variation; Genome-Wide Association Study; Glycated Hemoglobin; Histocompatibility Antigens Class I; Humans; Male; Metabolic Networks and Pathways; Polymorphism, Single Nucleotide; Receptors, Fc; United Kingdom; United States | 2022 |
HbA1C as a marker of retrograde glycaemic control in diabetes patient with co-existed beta-thalassaemia: A case report and a literature review.
Topics: Aged; beta-Thalassemia; Biomarkers; Blood Glucose; Diabetes Mellitus, Type 2; Diabetic Foot; Fructosamine; Glycated Hemoglobin; Humans; Hyperbaric Oxygenation; Hypoglycemic Agents; Insulin; Male | 2020 |
Effect of Ramadan fasting on glycaemic parameters & body mass index in type II diabetic patients: A meta-analysis.
Topics: Adult; Aged; Blood Glucose; Body Mass Index; Diabetes Mellitus, Type 2; Fasting; Female; Fructosamine; Glycated Hemoglobin; Glycemic Index; Humans; Hypoglycemia; Hypoglycemic Agents; Islam; Male; Middle Aged; Religion and Medicine | 2019 |
Review of methods for detecting glycemic disorders.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biomarkers; Blood Glucose; Blood Glucose Self-Monitoring; Cardiovascular Diseases; Child; Diabetes Mellitus, Type 2; Female; Fructosamine; Glucose Intolerance; Glucose Metabolism Disorders; Glucose Tolerance Test; Glycated Hemoglobin; Glycated Serum Albumin; Glycation End Products, Advanced; Humans; Hyperglycemia; Longitudinal Studies; Male; Middle Aged; Prediabetic State; Serum Albumin; Young Adult | 2020 |
Continuous glucose monitoring in patients with type 2 diabetes on hemodialysis.
Topics: Aged; Biomarkers; Blood Glucose; Blood Glucose Self-Monitoring; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Fructosamine; Glycated Hemoglobin; Glycated Serum Albumin; Glycation End Products, Advanced; Glycemic Control; Humans; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis; Serum Albumin | 2021 |
Beyond HbA1c and glucose: the role of nontraditional glycemic markers in diabetes diagnosis, prognosis, and management.
Topics: Biomarkers; Blood Glucose; Cross-Sectional Studies; Deoxyglucose; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Fasting; Fructosamine; Glycated Hemoglobin; Glycated Serum Albumin; Glycation End Products, Advanced; Humans; Hyperglycemia; Prognosis; Prospective Studies; Serum Albumin | 2014 |
Effects comparison between low glycemic index diets and high glycemic index diets on HbA1c and fructosamine for patients with diabetes: A systematic review and meta-analysis.
Topics: Adult; Aged; Biomarkers; Chi-Square Distribution; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diet, Diabetic; Female; Fructosamine; Glycated Hemoglobin; Glycemic Index; Glycemic Load; Humans; Male; Middle Aged; Treatment Outcome | 2015 |
The diagnosis of posttransplantation diabetes mellitus: meeting the challenges.
Topics: Blood Glucose; Diabetes Mellitus, Type 2; Fructosamine; Glucose Tolerance Test; Glycated Hemoglobin; Humans; Kidney Transplantation | 2015 |
The use of low-glycaemic index diets in diabetes control.
Topics: Albumins; Blood Glucose; Diabetes Mellitus, Type 2; Fructosamine; Glycated Hemoglobin; Glycemic Index; Humans | 2010 |
Using multiple measures of glycemia to support individualized diabetes management: recommendations for clinicians, patients, and payers.
Topics: Biomarkers; Blood Glucose; Blood Glucose Self-Monitoring; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Education, Medical, Continuing; Europe; Female; Fructosamine; Glycated Hemoglobin; Humans; Hyperglycemia; Hypoglycemia; Male; North America; Nurses; Physicians; Precision Medicine; Risk Factors | 2012 |
Glycated hemoglobin and liver disease in diabetes mellitus.
Topics: Cause of Death; Diabetes Complications; Diabetes Mellitus, Type 2; Fatty Liver; Fructosamine; Glycated Hemoglobin; Humans; Liver Cirrhosis; Liver Diseases; Predictive Value of Tests; Risk Factors; Survival Rate | 2005 |
Glucose monitoring in type 2 diabetes.
Topics: Bias; Blood Glucose; Blood Glucose Self-Monitoring; Calibration; Diabetes Mellitus, Type 2; Disease Progression; Fructosamine; Glycated Hemoglobin; Humans; Medical History Taking; Nursing Assessment; Patient Care Planning; Patient Education as Topic; Patient Selection; Practice Guidelines as Topic; Predictive Value of Tests; Reagent Strips; Reproducibility of Results; Self Care | 2001 |
Serum fructosamine as a screening test for type 2 diabetes.
Topics: Biomarkers; Blood Glucose; Blood Proteins; Diabetes Mellitus, Type 2; Diabetes, Gestational; Female; Fructosamine; Glycated Hemoglobin; Humans; Hyperglycemia; Infant, Newborn; Mass Screening; Pregnancy | 2000 |
108 trial(s) available for fructosamine and Diabetes Mellitus, Adult-Onset
| Article | Year |
|---|---|
Ultra-long-acting recombinant insulin for the treatment of diabetes mellitus in dogs.
Topics: Animals; Blood Glucose; Blood Glucose Self-Monitoring; Body Weight; Diabetes Mellitus; Diabetes Mellitus, Type 2; Dog Diseases; Dogs; Fructosamine; Hospitals, Animal; Hospitals, Teaching; Hypoglycemic Agents; Insulin; Insulin Glargine; Prospective Studies | 2022 |
Efficacy and Safety of Omija (
Topics: Blood Glucose; Diabetes Mellitus, Type 2; Double-Blind Method; Fructosamine; Glycated Hemoglobin; Humans; Hyperglycemia; Hypoglycemic Agents; Insulin; Schisandra | 2022 |
Effects of meditation on physiological and metabolic parameters in patients with type 2 diabetes mellitus "MindDM": study protocol for a randomized controlled trial.
Topics: Blood Glucose; Diabetes Mellitus, Type 2; Fructosamine; Glycated Hemoglobin; Humans; Hydrocortisone; Hydrogen; Insulin Resistance; Insulins; Meditation; Randomized Controlled Trials as Topic; Treatment Outcome | 2022 |
Ileo-colonic delivery of conjugated bile acids improves glucose homeostasis via colonic GLP-1-producing enteroendocrine cells in human obesity and diabetes.
Topics: Administration, Oral; Bile Acids and Salts; Biological Transport; Blood Glucose; Capsules; Cell Line; Cholestenones; Colon; Diabetes Mellitus, Type 2; Diffusion Chambers, Culture; Enteroendocrine Cells; Fasting; Fibroblast Growth Factors; Fructosamine; Gene Expression; Glucagon-Like Peptide 1; Homeostasis; Humans; Ileum; Insulin; Obesity; Postprandial Period; Primary Cell Culture; Receptors, G-Protein-Coupled | 2020 |
Association between Fluorescent Advanced Glycation End-Products and Vascular Complications in Type 2 Diabetic Patients.
Topics: Biomarkers; Cardiovascular Diseases; Case-Control Studies; Diabetes Mellitus, Type 2; Female; Fructosamine; Glycated Hemoglobin; Glycated Serum Albumin; Glycation End Products, Advanced; Humans; Male; Middle Aged; Oxidation-Reduction; Oxidative Stress; Pilot Projects; Serum Albumin; Serum Albumin, Human | 2017 |
Increased OGA Expression and Activity in Leukocytes from Patients with Diabetes: Correlation with Inflammation Markers.
Topics: Adult; Antigens, Neoplasm; Blood Glucose; Diabetes Mellitus, Type 2; Female; Fructosamine; Gene Expression Regulation, Enzymologic; Glycated Hemoglobin; Histone Acetyltransferases; Humans; Hyaluronoglucosaminidase; Leukocytes; Male; Middle Aged; RNA, Messenger | 2019 |
Okara Improved Blood Glucose Level in Vietnamese with Type 2 Diabetes Mellitus.
Topics: Adult; Blood Glucose; Diabetes Mellitus, Type 2; Diet; Dietary Fiber; Fasting; Female; Fructosamine; Humans; Male; Middle Aged; Nutrition Surveys; Plant Proteins; Polysaccharides; Soy Foods; Vietnam | 2019 |
Fructosamine is a useful indicator of hyperglycaemia and glucose control in clinical and epidemiological studies--cross-sectional and longitudinal experience from the AMORIS cohort.
Topics: Adult; Aged; Biomarkers; Blood Glucose; Cohort Studies; Cross-Over Studies; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Fructosamine; Glycated Hemoglobin; Humans; Hyperglycemia; Longitudinal Studies; Male; Middle Aged | 2014 |
Screening for type 2 diabetes and prediabetes in obese youth: evaluating alternate markers of glycemia - 1,5-anhydroglucitol, fructosamine, and glycated albumin.
Topics: Adolescent; Biomarkers; Child; Deoxyglucose; Diabetes Mellitus, Type 2; Female; Fructosamine; Glycated Serum Albumin; Glycation End Products, Advanced; Humans; Male; Mass Screening; Obesity; Prediabetic State; Serum Albumin | 2016 |
GSK256073 acutely regulates NEFA levels via HCA2 agonism but does not achieve durable glycaemic control in type 2 diabetes. A randomised trial.
Topics: Aged; Blood Glucose; Diabetes Mellitus, Type 2; Double-Blind Method; Fatty Acids, Nonesterified; Female; Fructosamine; Glycated Hemoglobin; Humans; Insulin; Male; Middle Aged; Receptors, G-Protein-Coupled; Receptors, Nicotinic; Treatment Outcome; Xanthines | 2015 |
Metabolic and physiologic effects from consuming a hunter-gatherer (Paleolithic)-type diet in type 2 diabetes.
Topics: Aged; Blood Pressure; Diabetes Mellitus, Type 2; Diet, Diabetic; Diet, Paleolithic; Diet, Western; Electrolytes; Female; Food; Fructosamine; Glucose Clamp Technique; Glycated Hemoglobin; Humans; Insulin Resistance; Lipids; Male; Middle Aged; San Francisco | 2015 |
Influence of glycemic control on gain in VO2 peak, in patients with type 2 diabetes enrolled in cardiac rehabilitation after an acute coronary syndrome. The prospective DARE study.
Topics: Acute Coronary Syndrome; Aged; Blood Glucose; Diabetes Mellitus, Type 2; Exercise Therapy; Female; Fructosamine; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin Aspart; Insulin Glargine; Male; Metformin; Middle Aged; Oxygen Consumption; Pulmonary Gas Exchange; Pulmonary Ventilation; Treatment Outcome | 2015 |
GLYCATED ALBUMIN AT 4 WEEKS CORRELATES WITH A1C LEVELS AT 12 WEEKS AND REFLECTS SHORT-TERM GLUCOSE FLUCTUATIONS.
Topics: Adult; Aged; Blood Glucose; Blood Glucose Self-Monitoring; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Fructosamine; Glycated Hemoglobin; Glycated Serum Albumin; Glycation End Products, Advanced; Humans; Hypoglycemic Agents; Male; Middle Aged; Serum Albumin; Time Factors | 2015 |
CPAP therapy for patients with sleep apnea and type 2 diabetes mellitus improves control of blood pressure.
Topics: Adult; Aged; Albuminuria; Blood Glucose; Blood Pressure; Comorbidity; Continuous Positive Airway Pressure; Diabetes Mellitus, Type 2; Female; Fructosamine; Glycated Hemoglobin; Humans; Hypertension; Lipids; Male; Middle Aged; Polysomnography; Sleep Apnea, Obstructive | 2017 |
A comparison of the health benefits of reduced-exertion high-intensity interval training (REHIT) and moderate-intensity walking in type 2 diabetes patients.
Topics: Adult; Biomarkers; Body Mass Index; Cross-Over Studies; Diabetes Mellitus, Type 2; England; Exercise; Fructosamine; Heart Rate; High-Intensity Interval Training; Humans; Hyperglycemia; Insulin Resistance; Male; Middle Aged; Obesity; Overweight; Patient Dropouts; Physical Exertion; Walking | 2017 |
Effects of xylooligosaccharides in type 2 diabetes mellitus.
Topics: Aged; Alanine Transaminase; Antioxidants; Aspartate Aminotransferases; Blood Glucose; Body Fat Distribution; Body Mass Index; Cholesterol; Creatinine; Diabetes Mellitus, Type 2; Dietary Supplements; Double-Blind Method; Fatty Acids, Volatile; Female; Fructosamine; Glycated Hemoglobin; Humans; Insulin; Lipids; Male; Middle Aged; Uric Acid; Xylans | 2008 |
A randomized behavioural trial targeting glycaemic index improves dietary, weight and metabolic outcomes in patients with type 2 diabetes.
Topics: Adult; Aged; Blood Glucose; Body Mass Index; Body Weight; Diabetes Mellitus, Type 2; Diet; Dietary Fats; Dietary Fiber; Energy Intake; Female; Fructosamine; Glycemic Index; Health Education; Health Promotion; Humans; Insulin Resistance; Male; Middle Aged; Rural Population; Sex Factors; Treatment Outcome; United States; Waist Circumference | 2009 |
A low-GI diet is associated with a short-term improvement of glycaemic control in Asian patients with type 2 diabetes.
Topics: Anthropometry; Blood Glucose; Diabetes Mellitus, Type 2; Diet, Diabetic; Energy Intake; Female; Follow-Up Studies; Fructosamine; Glycated Hemoglobin; Glycemic Index; Humans; Male; Postprandial Period; Waist Circumference | 2009 |
Supplementation with cholecalciferol does not improve glycaemic control in diabetic subjects with normal serum 25-hydroxyvitamin D levels.
Topics: Adult; Aged; Blood Glucose; C-Peptide; Calcifediol; Calcium; Cholecalciferol; Diabetes Mellitus, Type 2; Dietary Supplements; Female; Fructosamine; Glycated Hemoglobin; Humans; Insulin; Insulin, Long-Acting; Male; Metformin; Middle Aged; Young Adult | 2009 |
Effects of grape seed extract in Type 2 diabetic subjects at high cardiovascular risk: a double blind randomized placebo controlled trial examining metabolic markers, vascular tone, inflammation, oxidative stress and insulin sensitivity.
Topics: Aged; Albuminuria; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Double-Blind Method; Endothelium, Vascular; Female; Fructosamine; Grape Seed Extract; Humans; Insulin Resistance; Male; Middle Aged; Obesity; Oxidative Stress; Photoplethysmography; Placebos; Risk Factors | 2009 |
Effects of short-term therapy with different insulin secretagogues on glucose metabolism, lipid parameters and oxidative stress in newly diagnosed Type 2 Diabetes Mellitus.
Topics: Adult; Aged; Analysis of Variance; Blood Glucose; Carbamates; Chi-Square Distribution; Diabetes Mellitus, Type 2; Female; Fructosamine; Gliclazide; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Lipid Peroxidation; Lipids; Male; Middle Aged; Oxidative Stress; Piperidines; Postprandial Period; Sulfonylurea Compounds; Treatment Outcome | 2010 |
Hypoglycemic effect of bitter melon compared with metformin in newly diagnosed type 2 diabetes patients.
Topics: Adult; Asia; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Fructosamine; Fruit; Humans; Hypoglycemic Agents; Male; Medicine, Traditional; Metformin; Middle Aged; Momordica; Phytotherapy; Plant Preparations | 2011 |
Randomized trial on the influence of the length of two insulin pen needles on glycemic control and patient preference in obese patients with diabetes.
Topics: Aged; Body Mass Index; Cross-Over Studies; Deoxyglucose; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Fructosamine; Glycated Hemoglobin; Humans; Hyperglycemia; Hypoglycemia; Hypoglycemic Agents; Injections, Subcutaneous; Insulin; Male; Materials Testing; Middle Aged; Needles; Netherlands; Obesity; Patient Preference; Practice Guidelines as Topic; Self Administration | 2011 |
Safety, pharmacokinetic, and pharmacodynamic profiles of ipragliflozin (ASP1941), a novel and selective inhibitor of sodium-dependent glucose co-transporter 2, in patients with type 2 diabetes mellitus.
Topics: Adolescent; Adult; Aged; Area Under Curve; Blood Glucose; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Fructosamine; Glucosides; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Male; Middle Aged; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors; Thiophenes; Young Adult | 2011 |
Cerivastatin improves insulin sensitivity and insulin secretion in early-state obese type 2 diabetes.
Topics: Blood Glucose; Diabetes Mellitus; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Fructosamine; Glucose Clamp Technique; Glycated Hemoglobin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperinsulinism; Infusions, Intravenous; Insulin; Male; Middle Aged; Obesity; Placebos; Pyridines | 2002 |
Improved glycaemic control with metformin-glibenclamide combined tablet therapy (Glucovance) in Type 2 diabetic patients inadequately controlled on metformin.
Topics: Blood Glucose; Body Weight; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Double-Blind Method; Drug Combinations; Female; Fructosamine; Gastrointestinal Diseases; Glyburide; Glycated Hemoglobin; Humans; Hyperglycemia; Hypoglycemia; Hypoglycemic Agents; Lipids; Male; Metformin; Middle Aged; Tablets; Treatment Outcome | 2002 |
Repaglinide versus glibenclamide treatment of Type 2 diabetes during Ramadan fasting.
Topics: Biomarkers; Carbamates; Diabetes Mellitus, Type 2; Fasting; Feeding Behavior; Female; Fructosamine; Glyburide; Humans; Hypoglycemia; Hypoglycemic Agents; Islam; Malaysia; Male; Middle Aged; Piperidines; Risk Factors; Safety; Time Factors | 2002 |
Improved glucose control decreases the interaction of plasma low-density lipoproteins with arterial proteoglycans.
Topics: Adult; Aged; Analysis of Variance; Blood Glucose; Diabetes Mellitus, Type 2; Female; Fructosamine; Glipizide; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Lipids; Lipoproteins, LDL; Male; Metformin; Middle Aged; Proteoglycans | 2002 |
[Evaluation of the efficacy of biologically active dietary supplements in the diet therapy of patients with diabetes mellitus type II associated with obesity].
Topics: Aluminum Silicates; Blood Glucose; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diet, Diabetic; Dietary Supplements; Female; Fructosamine; Glycated Hemoglobin; Humans; Male; Middle Aged; Obesity; Treatment Outcome | 2002 |
A phytosterol-enriched spread improves the lipid profile of subjects with type 2 diabetes mellitus--a randomized controlled trial under free-living conditions.
Topics: Blood Glucose; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Food, Fortified; Fructosamine; Glycated Hemoglobin; Humans; Lipids; Male; Margarine; Middle Aged; Phytosterols; Residence Characteristics | 2003 |
Antihyperglycemic effect of oolong tea in type 2 diabetes.
Topics: Age of Onset; Biomarkers; Blood Glucose; Diabetes Mellitus, Type 2; Dietary Supplements; Fructosamine; Humans; Hypoglycemic Agents; Middle Aged; Tea; Treatment Outcome | 2003 |
Effect on glycemic control of exenatide (synthetic exendin-4) additive to existing metformin and/or sulfonylurea treatment in patients with type 2 diabetes.
Topics: Blood Glucose; Blood Pressure; Body Weight; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Exenatide; Female; Fructosamine; Glycated Hemoglobin; Heart Rate; Humans; Hypoglycemic Agents; Islets of Langerhans; Lipids; Male; Metformin; Middle Aged; Peptides; Sulfonylurea Compounds; Treatment Outcome; Venoms | 2003 |
Physiological changes in circulating mannose levels in normal, glucose-intolerant, and diabetic subjects.
Topics: Adult; Aged; Blood Glucose; Colorimetry; Coloring Agents; Diabetes Mellitus; Diabetes Mellitus, Type 2; Eating; Fasting; Female; Fructosamine; Glucose Intolerance; Glucose Tolerance Test; Glycated Hemoglobin; Humans; Male; Mannose; Middle Aged | 2003 |
Efficacy of glyburide/metformin tablets compared with initial monotherapy in type 2 diabetes.
Topics: Adult; Aged; Blood Glucose; Body Weight; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Combinations; Female; Fructosamine; Glyburide; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Male; Metformin; Middle Aged; Postprandial Period | 2003 |
[Efficiency of the vegetative tea in diet therapy for patients with obesity associated with diabetes mellitus type 2].
Topics: Adult; Aged; Beverages; Blood Glucose; Body Weight; C-Peptide; Cholesterol; Cholesterol, HDL; Diabetes Mellitus, Type 2; Diet Therapy; Female; Fructosamine; Glycated Hemoglobin; Humans; Insulin; Male; Medicine, Chinese Traditional; Middle Aged; Obesity; Plants, Medicinal; Thyroid Gland; Thyroid Hormones; Ultrasonography | 2003 |
[Transcapillary filtration of plasma proteins in patients with diabetes type II microangiopathy complications].
Topics: Adult; Aged; Albumins; alpha-Macroglobulins; Blood Proteins; Capillaries; Capillary Permeability; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Retinopathy; Disease Progression; Exudates and Transudates; Female; Fluorescein Angiography; Fructosamine; gamma-Globulins; Glycated Hemoglobin; Humans; Middle Aged; Skin | 2002 |
Effect of metformin on fibrinolytic parameters in insulin-treated, type 2 diabetic patients.
Topics: Aged; Analysis of Variance; Blood Glucose; Cholesterol, LDL; Diabetes Mellitus, Type 2; Fibrinogen; Fibrinolysis; Fructosamine; Humans; Hypoglycemic Agents; Insulin; Metformin; Middle Aged; Plasminogen Activator Inhibitor 1 | 2003 |
Evaluation of the efficacy of bitter gourd (momordica charantia) as an oral hypoglycemic agent--a randomized controlled clinical trial.
Topics: Aged; Blood Glucose; Diabetes Mellitus, Type 2; Female; Fructosamine; Humans; Hypoglycemic Agents; Male; Middle Aged; Momordica; Phytotherapy; Riboflavin | 2003 |
Addition of biphasic insulin aspart 30 to rosiglitazone in type 2 diabetes mellitus that is poorly controlled with glibenclamide monotherapy.
Topics: Adult; Aged; Biphasic Insulins; Blood Glucose; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Fructosamine; Glyburide; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Insulin Aspart; Insulin, Isophane; Male; Middle Aged; Rosiglitazone; Thiazolidinediones; Treatment Outcome | 2003 |
A prospective, randomized, multicentered controlled trial to compare the annual glycemic and quality outcomes of patients with diabetes mellitus monitored with weekly fructosamine testing versus usual care.
Topics: Alcohol Drinking; Anxiety; Biomarkers; Blood Glucose; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Fructosamine; Glycated Hemoglobin; Humans; Male; Middle Aged; Quality of Life; Racial Groups; Sexual Behavior; Smoking; Social Behavior | 2004 |
Postprandial versus preprandial dosing of biphasic insulin aspart in elderly type 2 diabetes patients.
Topics: Aged; Biomarkers; Biphasic Insulins; Blood Glucose; Cross-Over Studies; Diabetes Mellitus, Type 2; Drug Administration Schedule; Eating; Female; Fructosamine; Humans; Hypoglycemic Agents; Insulin; Insulin Aspart; Insulin, Isophane; Kinetics; Postprandial Period; Racial Groups; Safety | 2004 |
Identification of Amadori-modified plasma proteins in type 2 diabetes and the effect of short-term intensive insulin treatment.
Topics: Blood Glucose; Blood Proteins; Body Mass Index; Diabetes Mellitus, Type 2; Fructosamine; Humans; Hypoglycemic Agents; Immunoglobulin Heavy Chains; Immunoglobulin Light Chains; Insulin; Middle Aged; Obesity; Serum Albumin; Serum Globulins; Thinness | 2005 |
Improvement in C-reactive protein and advanced glycosylation end-products in poorly controlled diabetics is independent of glucose control.
Topics: Administration, Oral; Adult; Analysis of Variance; Blood Glucose; C-Reactive Protein; Diabetes Mellitus, Type 2; Female; Fructosamine; Glycated Hemoglobin; Glycation End Products, Advanced; Humans; Hypoglycemic Agents; Insulin; Male; Middle Aged | 2006 |
Catalytic amounts of fructose may improve glucose tolerance in subjects with uncontrolled non-insulin-dependent diabetes.
Topics: Aged; Blood Glucose; Carbohydrate Metabolism; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Fructosamine; Fructose; Glucose Tolerance Test; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Male; Middle Aged; Postprandial Period; Sweetening Agents; Treatment Outcome; Triglycerides | 2006 |
Effects of blood pressure lowering and metabolic control on systolic left ventricular function in Type II diabetes mellitus.
Topics: Aged; Antihypertensive Agents; Blood Glucose; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Echocardiography, Doppler; Female; Follow-Up Studies; Fructosamine; Glycated Hemoglobin; Heart Ventricles; Humans; Hypertension; Male; Middle Aged; Organ Size; Ventricular Dysfunction, Left | 2006 |
Efficacy, tolerability, and safety of a novel once-daily extended-release metformin in patients with type 2 diabetes.
Topics: Adolescent; Adult; Aged; Blood Glucose; Delayed-Action Preparations; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Double-Blind Method; Female; Fructosamine; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Male; Metformin; Middle Aged | 2006 |
Beneficial effects of a long-term oral L-arginine treatment added to a hypocaloric diet and exercise training program in obese, insulin-resistant type 2 diabetic patients.
Topics: Administration, Oral; Arginine; Blood Glucose; Blood Pressure; Body Weight; Combined Modality Therapy; Diabetes Mellitus, Type 2; Diet, Reducing; Energy Intake; Exercise; Female; Fructosamine; Humans; Insulin; Insulin Resistance; Male; Middle Aged; Obesity; Triglycerides | 2006 |
Results of the glucose-lowering effect of WelChol study (GLOWS): a randomized, double-blind, placebo-controlled pilot study evaluating the effect of colesevelam hydrochloride on glycemic control in subjects with type 2 diabetes.
Topics: Aged; Allylamine; Anticholesteremic Agents; Apolipoproteins B; Blood Glucose; Cholesterol; Cholesterol, LDL; Colesevelam Hydrochloride; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Fructosamine; Gastrointestinal Diseases; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Middle Aged; Pilot Projects | 2007 |
Metabolic effects of time-released garlic powder tablets in type 2 diabetes mellitus: the results of double-blinded placebo-controlled study.
Topics: Adult; Blood Glucose; Cholesterol; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Fructosamine; Garlic; Humans; Lipids; Male; Middle Aged; Placebos; Powders; Tablets | 2008 |
Effects of health education on glycemic control during holiday time in patients with type 2 diabetes mellitus.
Topics: Aged; Blood Glucose; Blood Pressure; Body Weight; Diabetes Complications; Diabetes Mellitus, Type 2; Female; Fructosamine; Glycated Hemoglobin; Holidays; Hospitals, Veterans; Humans; Male; Middle Aged; Pamphlets; Patient Education as Topic; Program Evaluation; Risk Factors; Self Care; Taiwan; Veterans | 2008 |
Pharmacokinetic, pharmacodynamic, and tolerability profiles of the dipeptidyl peptidase-4 inhibitor alogliptin: a randomized, double-blind, placebo-controlled, multiple-dose study in adult patients with type 2 diabetes.
Topics: Adult; Aged; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Dose-Response Relationship, Drug; Double-Blind Method; Female; Fructosamine; Glycated Hemoglobin; Humans; Insulin; Male; Middle Aged; Piperidines; Placebos; Time Factors; Treatment Outcome; Uracil | 2008 |
Effects of pre-germinated brown rice on blood glucose and lipid levels in free-living patients with impaired fasting glucose or type 2 diabetes.
Topics: Adult; Aged; Blood Glucose; Cholesterol; Cross-Over Studies; Diabetes Mellitus, Type 2; Diet; Fasting; Female; Fructosamine; Glucose Intolerance; Humans; Lipids; Male; Middle Aged; Oryza; Residence Characteristics; Time Factors; Triglycerides | 2008 |
Comparison of insulin with or without continuation of oral hypoglycemic agents in the treatment of secondary failure in NIDDM patients.
Topics: Analysis of Variance; Biomarkers; Blood Glucose; Body Mass Index; C-Peptide; Cholesterol; Cholesterol, HDL; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Fructosamine; Gliclazide; Glipizide; Glyburide; Glycated Hemoglobin; Hexosamines; Humans; Hypoglycemic Agents; Insulin; Male; Metformin; Middle Aged; Treatment Failure; Triglycerides | 1995 |
Effects of Vitamin E on susceptibility of low-density lipoprotein and low-density lipoprotein subfractions to oxidation and on protein glycation in NIDDM.
Topics: Aged; Blood Glucose; Blood Proteins; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Copper; Diabetes Mellitus, Type 2; Fructosamine; Glycated Hemoglobin; Glycated Serum Albumin; Glycated Serum Proteins; Glycation End Products, Advanced; Glycoproteins; Glycosylation; Hexosamines; Homeostasis; Humans; Insulin; Lipoproteins, LDL; Male; Middle Aged; Oxidation-Reduction; Serum Albumin; Thiobarbituric Acid Reactive Substances; Time Factors; Triglycerides; Vitamin E | 1995 |
Dietary substitution of medium chain triglycerides in subjects with non-insulin-dependent diabetes mellitus in an ambulatory setting: impact on glycemic control and insulin-mediated glucose metabolism.
Topics: Adult; Ambulatory Care; Blood Glucose; Blood Glucose Self-Monitoring; Cross-Over Studies; Diabetes Mellitus, Type 2; Diet Records; Dietary Fats; Eating; Female; Fructosamine; Glucose; Glucose Clamp Technique; Hexosamines; Humans; Insulin; Male; Middle Aged; Single-Blind Method; Time Factors; Triglycerides | 1994 |
Glomerular hyperfiltration in young Polynesians with type 2 diabetes.
Topics: Adult; Age Factors; Aged; Albuminuria; Blood Glucose; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Fructosamine; Glomerular Filtration Rate; Hexosamines; Humans; Male; Middle Aged; New Zealand; Polynesia; Reference Values; White People | 1994 |
UK Prospective Diabetes Study (UKPDS). XI: Biochemical risk factors in type 2 diabetic patients at diagnosis compared with age-matched normal subjects.
Topics: Acetylglucosaminidase; Adult; Age Factors; Aged; Albuminuria; Biomarkers; Blood Glucose; C-Peptide; Cholesterol; Creatinine; Diabetes Mellitus, Type 2; Female; Fructosamine; Glycated Hemoglobin; Growth Hormone; Hexosamines; Humans; Hyperinsulinism; Insulin; Laboratories; Male; Middle Aged; Prevalence; Prospective Studies; Quality Control; Reference Values; Risk Factors; Sex Characteristics; Triglycerides; United Kingdom | 1994 |
The effects of enalapril and nifedipine on carbohydrate and lipid metabolism in NIDDM.
Topics: Apolipoprotein A-I; Apolipoproteins B; Biomarkers; Blood Glucose; Blood Pressure; China; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Creatinine; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Double-Blind Method; Enalapril; Fructosamine; Glycated Hemoglobin; Hexosamines; Hong Kong; Humans; Hypertension; Lipids; Nifedipine; Triglycerides | 1994 |
Effect of a high-monounsaturated fat diet enriched with avocado in NIDDM patients.
Topics: Biomarkers; Blood Glucose; Body Weight; Cholesterol; Cholesterol, LDL; Diabetes Mellitus, Type 2; Diet, Diabetic; Dietary Carbohydrates; Dietary Fats; Dietary Fats, Unsaturated; Fatty Acids, Monounsaturated; Female; Fructosamine; Hexosamines; Humans; Middle Aged; Olive Oil; Plant Oils; Triglycerides; Vegetables | 1994 |
Effects of oral magnesium supplementation on plasma lipid concentrations in patients with non-insulin-dependent diabetes mellitus.
Topics: Administration, Oral; Blood Glucose; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Diabetes Mellitus, Type 2; Erythrocytes; Female; Fructosamine; Glycated Hemoglobin; Hexosamines; Humans; Lipids; Magnesium; Male; Middle Aged; Triglycerides | 1994 |
Serum immunoglobulin concentrations in diabetic patients.
Topics: Adult; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Fructosamine; Glycated Hemoglobin; Hexosamines; Humans; Hyperglycemia; Immunoglobulin A; Immunoglobulin G; Immunoglobulin M; Male; Middle Aged; Regression Analysis; Statistics as Topic | 1994 |
Effects of a new oral hypoglycaemic agent, repaglinide, on metabolic control in sulphonylurea-treated patients with NIDDM.
Topics: Aged; Blood Glucose; Carbamates; Diabetes Mellitus, Type 2; Female; Fructosamine; Gliclazide; Glyburide; Glycated Hemoglobin; Hexosamines; Humans; Hypoglycemic Agents; Lipids; Male; Middle Aged; Piperidines; Tolbutamide | 1993 |
Renal function and insulin sensitivity during simvastatin treatment in type 2 (non-insulin-dependent) diabetic patients with microalbuminuria.
Topics: Aged; Albuminuria; Anticholesteremic Agents; Apolipoproteins B; Biomarkers; Blood Glucose; Blood Pressure; Cholesterol; Cholesterol, LDL; Diabetes Mellitus, Type 2; Double-Blind Method; Energy Intake; Female; Fructosamine; Glomerular Filtration Rate; Glycated Hemoglobin; Hexosamines; Humans; Hypercholesterolemia; Insulin; Kidney; Lovastatin; Male; Placebos; Simvastatin; Time Factors | 1993 |
Metabolic and hemodynamic effects of metformin and glibenclamide in normotensive NIDDM patients.
Topics: Biomarkers; Blood Glucose; Blood Pressure; Cardiac Output; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Diabetes Mellitus, Type 2; Female; Fructosamine; Glyburide; Glycated Hemoglobin; Heart Rate; Hemodynamics; Hexosamines; Humans; Male; Metformin; Middle Aged; Posture; Triglycerides; Vascular Resistance | 1993 |
Muslims with non-insulin dependent diabetes fasting during Ramadan: treatment with glibenclamide.
Topics: Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Fasting; Female; Fructosamine; Glyburide; Glycated Hemoglobin; Hexosamines; Humans; Hypoglycemia; Islam; Male; Middle Aged | 1993 |
Effects of metformin on insulin resistance, risk factors for cardiovascular disease, and plasminogen activator inhibitor in NIDDM subjects. A study of two ethnic groups.
Topics: Albuminuria; Asia; Biomarkers; Blood Glucose; C-Peptide; Cardiovascular Diseases; Cholesterol; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Double-Blind Method; Ethnicity; Fructosamine; Hexosamines; Humans; Insulin; Insulin Resistance; Islets of Langerhans; Metabolic Clearance Rate; Metformin; Plasminogen Activator Inhibitor 1; Platelet Aggregation; Risk Factors; Triglycerides; United Kingdom; White People | 1993 |
Does suppression of postprandial blood glucose excursions by the alpha-glucosidase inhibitor miglitol improve insulin sensitivity in diet-treated type II diabetic patients?
Topics: 1-Deoxynojirimycin; Biomarkers; Blood Glucose; Cholesterol; Combined Modality Therapy; Diabetes Mellitus, Type 2; Diet, Diabetic; Double-Blind Method; Enzyme Inhibitors; Female; Fructosamine; Glucosamine; Glycoside Hydrolase Inhibitors; Humans; Imino Pyranoses; Insulin; Male; Metabolic Clearance Rate; Middle Aged; Triglycerides | 1996 |
Troglitazone, an insulin action enhancer, improves metabolic control in NIDDM patients. Troglitazone Study Group.
Topics: Adult; Aged; Blood Glucose; C-Peptide; Cholesterol; Chromans; Diabetes Mellitus, Type 2; Double-Blind Method; Fasting; Fatty Acids, Nonesterified; Female; Fructosamine; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Leukocyte Count; Lipoproteins, HDL; Lipoproteins, LDL; Male; Middle Aged; Neutrophils; Thiazoles; Thiazolidinediones; Triglycerides; Troglitazone | 1996 |
Comparison of different insulin regimens in elderly patients with NIDDM.
Topics: Aged; Apolipoprotein A-I; Apolipoproteins B; Blood Glucose; C-Peptide; Cholesterol; Cholesterol, HDL; Costs and Cost Analysis; Diabetes Mellitus, Type 2; Drug Administration Schedule; Fatty Acids, Nonesterified; Female; Fructosamine; Glyburide; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Islets of Langerhans; Lipids; Lipoprotein(a); Male; Netherlands; Triglycerides | 1996 |
A double-masked placebo-controlled trial assessing effects of various doses of BTS 67,582, a novel insulinotropic agent, on fasting hyperglycemia in NIDDM patients.
Topics: Adult; Aged; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Administration Schedule; Fasting; Female; Fructosamine; Glycated Hemoglobin; Guanidines; Humans; Hyperglycemia; Hypoglycemic Agents; Insulin; Male; Middle Aged; Patient Selection; Placebos; Postmenopause | 1997 |
Combination of low-dose niacin and pravastatin improves the lipid profile in diabetic patients without compromising glycemic control.
Topics: Adult; Aged; Anticholesteremic Agents; Blood Glucose; Cholesterol, LDL; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Enzyme Inhibitors; Female; Fructosamine; Humans; Hypercholesterolemia; Lipoprotein(a); Male; Middle Aged; Niacin; Pravastatin; Prospective Studies | 1997 |
Complementary insulin therapy improves blood glucose and serum lipid parameters in type 2 (non-insulin-dependent) diabetic patients. II. Effects on serum lipids, lipoproteins and apoproteins.
Topics: Adult; Aged; Apolipoproteins; Blood Glucose; Cholesterol; Diabetes Mellitus, Type 2; Female; Fructosamine; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Lipids; Lipoproteins; Male; Middle Aged; Prospective Studies; Triglycerides | 1997 |
[The concentration of glucose, glycosylated hemoglobin and fructosamine in blood of patients with cerebral hemorrhage in the acute stage of the disease].
Topics: Aged; Blood Glucose; Cerebral Hemorrhage; Diabetes Mellitus, Type 2; Fructosamine; Glycated Hemoglobin; Humans; Prognosis | 1995 |
Comparison of a carbohydrate-rich diet and diets rich in stearic or palmitic acid in NIDDM patients. Effects on lipids, glycemic control, and diurnal blood pressure.
Topics: Adult; Blood Glucose; Blood Pressure; Circadian Rhythm; Cohort Studies; Cross-Over Studies; Diabetes Mellitus, Type 2; Dietary Carbohydrates; Dietary Fats; Endothelins; Fatty Acids; Female; Fructosamine; Glycated Hemoglobin; Humans; Lipids; Lipoprotein(a); Male; Middle Aged; Palmitic Acid; Stearic Acids; Triglycerides | 1997 |
The Fasting Hyperglycaemia Study: I. Subject identification and recruitment for a non-insulin-dependent diabetes prevention trial.
Topics: Adult; Aged; Blood Glucose; Diabetes Mellitus, Type 2; England; Fasting; Female; France; Fructosamine; Gliclazide; Glucose Tolerance Test; Glycated Hemoglobin; Humans; Hyperglycemia; Hypoglycemic Agents; Life Style; Male; Middle Aged; Patient Selection; Risk Factors; Sulfonylurea Compounds; Time Factors; World Health Organization | 1997 |
Metabolic effects of tibolone in postmenopausal women with non-insulin dependent diabetes mellitus.
Topics: Anabolic Agents; Blood Glucose; Diabetes Mellitus, Type 2; Fasting; Female; Fructosamine; Humans; Insulin; Lipid Metabolism; Lipids; Longitudinal Studies; Middle Aged; Norpregnenes; Postmenopause; Postprandial Period; Prospective Studies; Time Factors | 1998 |
The effect of magnesium supplementation in increasing doses on the control of type 2 diabetes.
Topics: Adult; Aged; Blood Glucose; Body Mass Index; Body Weight; Diabetes Mellitus, Type 2; Dietary Supplements; Dose-Response Relationship, Drug; Double-Blind Method; Fasting; Female; Fructosamine; Glucose Tolerance Test; Glycated Hemoglobin; Humans; Hyperglycemia; Magnesium; Male; Middle Aged; Reference Values | 1998 |
Pramlintide, a synthetic analog of human amylin, improves the metabolic profile of patients with type 2 diabetes using insulin. The Pramlintide in Type 2 Diabetes Group.
Topics: Adult; Aged; Amyloid; Biomarkers; Body Weight; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combination; Female; Fructosamine; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Islet Amyloid Polypeptide; Male; Middle Aged; Placebos; Triglycerides | 1998 |
Multicenter randomized trial of a comprehensive prepared meal program in type 2 diabetes.
Topics: Adult; Aged; Blood Glucose; Blood Pressure; Body Weight; Diabetes Mellitus, Type 2; Diet Records; Diet, Diabetic; Energy Intake; Female; Food Preferences; Fructosamine; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Lipids; Male; Middle Aged; Risk Factors; United States; Voluntary Health Agencies | 1999 |
Effect of pravastatin on erythrocyte rheological and biochemical properties in poorly controlled Type 2 diabetic patients.
Topics: Anticholesteremic Agents; Blood Pressure; Cholesterol; Cholesterol, HDL; Diabetes Mellitus, Type 2; Double-Blind Method; Electrolytes; Erythrocyte Deformability; Erythrocyte Membrane; Erythrocytes; Female; Fructosamine; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Male; Middle Aged; Phospholipids; Placebos; Pravastatin; Reference Values; Rheology | 1999 |
Konjac-mannan (glucomannan) improves glycemia and other associated risk factors for coronary heart disease in type 2 diabetes. A randomized controlled metabolic trial.
Topics: Apolipoproteins; Blood Glucose; Blood Pressure; Body Weight; Cholesterol; Coronary Disease; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diet, Diabetic; Dietary Fiber; Female; Fructosamine; Humans; Insulin; Male; Mannans; Middle Aged; Obesity; Risk Factors; Triglycerides | 1999 |
Flexible prandial glucose regulation with repaglinide in patients with type 2 diabetes.
Topics: Aged; Area Under Curve; Blood Glucose; Carbamates; Cholesterol; Diabetes Mellitus, Type 2; Eating; Female; Fructosamine; Humans; Hypoglycemic Agents; Indicators and Reagents; Male; Middle Aged; Nitroblue Tetrazolium; Piperidines; Prospective Studies; Triglycerides | 1999 |
A comparison of troglitazone and metformin on insulin requirements in euglycemic intensively insulin-treated type 2 diabetic patients.
Topics: Blood Glucose; Body Weight; C-Peptide; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Chromans; Circadian Rhythm; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Drug Therapy, Combination; Fatty Acids, Nonesterified; Female; Fructosamine; Humans; Hypoglycemic Agents; Insulin; Insulin Infusion Systems; Male; Metformin; Middle Aged; Thiazoles; Thiazolidinediones; Triglycerides; Troglitazone | 1999 |
Soluble L-selectin level is a marker for coronary artery disease in type 2 diabetic patients.
Topics: Aged; Biomarkers; Cholesterol, LDL; Coronary Disease; Diabetes Mellitus, Type 2; Female; Fructosamine; Glycated Hemoglobin; Humans; L-Selectin; Male; Myocardial Ischemia; Solubility; Triglycerides | 1999 |
Addition of low-dose rosiglitazone to sulphonylurea therapy improves glycaemic control in Type 2 diabetic patients.
Topics: Adult; Aged; Blood Glucose; C-Peptide; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combination; Europe; Female; Fructosamine; Gliclazide; Glipizide; Glyburide; Humans; Hypoglycemic Agents; Insulin; Male; Middle Aged; Rosiglitazone; Safety; Thiazoles; Thiazolidinediones; Triglycerides | 2000 |
Rosiglitazone short-term monotherapy lowers fasting and post-prandial glucose in patients with type II diabetes.
Topics: Aged; Blood Glucose; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Double-Blind Method; Eating; Fasting; Female; Fructosamine; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Lipids; Male; Middle Aged; Rosiglitazone; Thiazoles; Thiazolidinediones; Time Factors | 2000 |
Rosiglitazone taken once daily provides effective glycaemic control in patients with Type 2 diabetes mellitus.
Topics: Adult; Aged; Blood Glucose; Body Mass Index; C-Peptide; Diabetes Mellitus, Type 2; Double-Blind Method; Europe; Female; Fructosamine; Humans; Hypoglycemic Agents; Insulin; Male; Middle Aged; Placebos; Rosiglitazone; Thiazoles; Thiazolidinediones; Time Factors | 2000 |
Herbal tea in the treatment of diabetes mellitus.
Topics: Aged; Beverages; Blood Glucose; Diabetes Mellitus, Type 2; Dietary Sucrose; Female; Food; Food, Formulated; Fructosamine; Glycated Hemoglobin; Humans; Male; Middle Aged; Phytotherapy; Placebos | 2000 |
Rosiglitazone monotherapy improves glycaemic control in patients with type 2 diabetes: a twelve-week, randomized, placebo-controlled study.
Topics: Adult; Aged; Aged, 80 and over; Blood Glucose; Body Weight; C-Peptide; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Fructosamine; Glycated Hemoglobin; Humans; Insulin; Lipids; Male; Middle Aged; Placebos; Rosiglitazone; Thiazoles; Thiazolidinediones | 1999 |
Repaglinide improves blood glucose control in sulphonylurea-naive type 2 diabetes.
Topics: Area Under Curve; Blood Glucose; Carbamates; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Administration Schedule; Fasting; Fructosamine; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Middle Aged; Piperidines; Placebos; Postprandial Period; Time Factors | 2001 |
A double-blind trial on the effects of atorvastatin on glycemic control in Japanese diabetic patients with hypercholesterolemia.
Topics: Adult; Aged; Anticholesteremic Agents; Apolipoproteins; Atorvastatin; Blood Glucose; Cholesterol; Deoxyglucose; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Fructosamine; Glycated Hemoglobin; Heptanoic Acids; Humans; Hypercholesterolemia; Male; Middle Aged; Pyrroles | 2001 |
Effect of a chicken-based diet on renal function and lipid profile in patients with type 2 diabetes: a randomized crossover trial.
Topics: Adult; Albuminuria; Animals; Apolipoproteins B; Blood Glucose; Blood Pressure; Chickens; Cholesterol; Cross-Over Studies; Diabetes Mellitus, Type 2; Dietary Proteins; Female; Fructosamine; Glomerular Filtration Rate; Glycated Hemoglobin; Humans; Lipoproteins, HDL; Lipoproteins, LDL; Male; Meat; Middle Aged; Poultry; Reference Values; Smoking; Triglycerides | 2002 |
Serial change in 123I-MIBG myocardial scintigraphy in non-insulin-dependent diabetes mellitus.
Topics: 3-Iodobenzylguanidine; Blood Glucose; Diabetes Mellitus, Type 2; Electrocardiography; Evaluation Studies as Topic; Female; Follow-Up Studies; Fructosamine; Heart; Humans; Male; Middle Aged; Myocardium; Neural Conduction; Radionuclide Ventriculography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Sex Factors; Tibial Nerve; Time Factors; Treatment Outcome | 2002 |
Four-week low-glycemic index breakfast with a modest amount of soluble fibers in type 2 diabetic men.
Topics: Adipose Tissue; Adult; Aged; Apolipoproteins B; Blood Glucose; Carrier Proteins; Cholesterol; Cholesterol Ester Transfer Proteins; Cross-Over Studies; Diabetes Mellitus, Type 2; Dietary Carbohydrates; Dietary Fiber; Double-Blind Method; Fructosamine; Glucose; Glycated Hemoglobin; Glycoproteins; Humans; Insulin; Leptin; Lipid Metabolism; Male; Middle Aged; Receptors, Cytoplasmic and Nuclear; RNA, Messenger; Transcription Factors; Triglycerides | 2002 |
Mosapride, a 5HT-4 receptor agonist, improves insulin sensitivity and glycaemic control in patients with Type II diabetes mellitus.
Topics: Base Sequence; Benzamides; Blood Glucose; Diabetes Mellitus, Type 2; DNA Primers; Female; Fructosamine; Gastrointestinal Agents; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Lipids; Male; Middle Aged; Morpholines; Placebos; Receptors, Serotonin; Receptors, Serotonin, 5-HT4; Reverse Transcriptase Polymerase Chain Reaction; Serotonin Receptor Agonists | 2002 |
[Mechanisms of hypoglycemic action of benfluorex].
Topics: Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Female; Fenfluramine; Fructosamine; Glycated Hemoglobin; Hexosamines; Humans; Hypolipidemic Agents; Insulin; Liver; Male; Middle Aged | 1992 |
Beneficial effect of low-glycemic index diet in overweight NIDDM subjects.
Topics: Blood Glucose; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diet, Diabetic; Diet, Reducing; Dietary Carbohydrates; Female; Fructosamine; Hexosamines; Humans; Male; Middle Aged; Obesity; Triglycerides; Weight Loss | 1992 |
Maintenance of sulfonylurea responsiveness in NIDDM. Randomized double-blind study of intermittent glyburide therapy.
Topics: Biomarkers; Blood Glucose; Diabetes Mellitus, Type 2; Diet, Diabetic; Double-Blind Method; Drug Administration Schedule; Female; Fructosamine; Glyburide; Glycated Hemoglobin; Hexosamines; Humans; Insulin; Male; Middle Aged; Prospective Studies | 1992 |
Telematic expert system Diabeto. New tool for diet self-monitoring for diabetic patients.
Topics: Adult; Biomarkers; Computer-Assisted Instruction; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diet, Diabetic; Energy Intake; Feeding Behavior; Female; Fructosamine; Glycated Hemoglobin; Hexosamines; Humans; Male; Middle Aged; Patient Education as Topic; Patient Satisfaction; Surveys and Questionnaires | 1992 |
The effects of dexfenfluramine on blood glucose control in patients with type 2 diabetes.
Topics: Biomarkers; Blood Glucose; Blood Pressure; Cholesterol; Diabetes Mellitus; Diabetes Mellitus, Type 2; Double-Blind Method; Fenfluramine; Fructosamine; Glycated Hemoglobin; Hexosamines; Humans; Hypoglycemic Agents; Obesity; Weight Loss | 1992 |
The use of low glycaemic index foods improves metabolic control of diabetic patients over five weeks.
Topics: Adult; Apolipoproteins; Biomarkers; Blood Glucose; Cholesterol; Cholesterol, HDL; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diet, Diabetic; Dietary Carbohydrates; Eating; Female; Fructosamine; Glycated Hemoglobin; Hexosamines; Humans; Insulin; Male; Middle Aged; Phospholipids; Triglycerides | 1992 |
Post-prandial glycaemic reduction by an alpha-glucosidase inhibitor in type 2 diabetic patients with therapeutically attained basal normoglycaemia.
Topics: 1-Deoxynojirimycin; Biomarkers; Blood Glucose; Body Weight; Diabetes Mellitus, Type 2; Diet, Diabetic; Eating; Female; Fructosamine; Glucosamine; Glycated Hemoglobin; Glycoside Hydrolase Inhibitors; Hexosamines; Humans; Hypoglycemic Agents; Imino Pyranoses; Insulin; Insulin, Long-Acting; Lipoproteins, HDL; Lipoproteins, LDL; Male; Middle Aged; Reference Values; Time Factors; Triglycerides | 1991 |
A pilot clinical trial of a new oral hypoglycemic agent, CS-045, in patients with non-insulin dependent diabetes mellitus.
Topics: Biomarkers; Blood Glucose; Body Mass Index; Chromans; Diabetes Mellitus, Type 2; Diet, Diabetic; Female; Fructosamine; Glycated Hemoglobin; Hexosamines; Humans; Hypoglycemic Agents; Insulin; Male; Middle Aged; Pilot Projects; Thiazoles; Thiazolidinediones; Troglitazone | 1991 |
Effects of alpha-glucosidase inhibition and viscous fibre on diabetic control and postprandial gut hormone responses.
Topics: 1-Deoxynojirimycin; Adult; Aged; Biomarkers; Blood Glucose; Cholesterol; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Dietary Fiber; Double-Blind Method; Eating; Female; Fructosamine; Galactans; Glucosamine; Glycoside Hydrolase Inhibitors; Hexosamines; Humans; Imino Pyranoses; Male; Mannans; Middle Aged; Plant Gums; Random Allocation; Triglycerides | 1990 |
Effect of enprostil on glucose and lipid metabolism in type 2 diabetes.
Topics: Aged; Blood Glucose; Cholesterol; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Double-Blind Method; Eating; Enprostil; Female; Fructosamine; Gastric Inhibitory Polypeptide; Hexosamines; Humans; Insulin; Kinetics; Male; Middle Aged; Prostaglandins E, Synthetic; Triglycerides | 1989 |
A trial of the calcium antagonist felodipine in hypertensive type 2 diabetic patients.
Topics: Apolipoproteins; Blood Glucose; Blood Pressure; Clinical Trials as Topic; Creatinine; Diabetes Mellitus, Type 2; Double-Blind Method; Felodipine; Female; Fructosamine; Glycated Hemoglobin; Heart Rate; Hexosamines; Humans; Hypertension; Lipids; Male; Middle Aged; Random Allocation | 1989 |
The effects of verapamil, diltiazem, nifedipine and propranolol on metabolic control in hypertensives with non-insulin dependent diabetes mellitus.
Topics: Aged; Blood Glucose; Blood Pressure; Cholesterol; Diabetes Mellitus, Type 2; Diltiazem; Female; Fructosamine; Glycated Hemoglobin; Heart Rate; Hexosamines; Humans; Hypertension; Insulin; Male; Middle Aged; Nifedipine; Propranolol; Triglycerides; Verapamil | 1989 |
Low-glycemic-index starchy foods in the diabetic diet.
Topics: Aged; Blood Glucose; Body Weight; C-Peptide; Cholesterol; Creatinine; Diabetes Mellitus, Type 2; Dietary Carbohydrates; Female; Fructosamine; Glycated Hemoglobin; Hexosamines; Humans; Male; Middle Aged | 1988 |
252 other study(ies) available for fructosamine and Diabetes Mellitus, Adult-Onset
| Article | Year |
|---|---|
The Accuracy of Hemoglobin A1c and Fructosamine Evaluated by Long-Term Continuous Glucose Monitoring in Patients with Type 2 Diabetes Undergoing Hemodialysis.
Topics: Blood Glucose; Blood Glucose Self-Monitoring; Diabetes Mellitus, Type 2; Fructosamine; Glycated Hemoglobin; Humans; Renal Dialysis | 2022 |
Hemoglobin A1c and Fructosamine Evaluated in Patients with Type 2 Diabetes Receiving Peritoneal Dialysis Using Long-Term Continuous Glucose Monitoring.
Topics: Blood Glucose; Blood Glucose Self-Monitoring; Diabetes Mellitus, Type 2; Fructosamine; Glucose; Glycated Hemoglobin; Humans; Peritoneal Dialysis; Serum Albumin | 2022 |
Does Preoperative Glycemic Control Restore Immune Defense Against Implant-related Infection in Mice With Diabetes?
Topics: Animals; Biomarkers; Blood Glucose; Diabetes Mellitus, Type 2; Escherichia coli; Female; Fructosamine; Glycated Hemoglobin; Glycemic Control; Hyperglycemia; Insulin; Mice; Mice, Inbred C57BL; Staphylococcus aureus | 2022 |
In vitro Interference of Uric Acid on Serum Fructosamine and Blood HbA1c.
Topics: Blood Glucose; Diabetes Mellitus, Type 2; Fructosamine; Glycated Hemoglobin; Humans; Uric Acid | 2022 |
Longitudinal analysis of the rectal microbiome in dogs with diabetes mellitus after initiation of insulin therapy.
Topics: Animals; Diabetes Mellitus, Type 2; Dogs; Fructosamine; Gastrointestinal Microbiome; Humans; Insulin; Insulin, Regular, Human; Pilot Projects; RNA, Ribosomal, 16S | 2022 |
Effects of coconut oil long-term supplementation in Wistar rats during metabolic syndrome - regulation of metabolic conditions involving glucose homeostasis, inflammatory signals, and oxidative stress.
Topics: Animals; Blood Glucose; Coconut Oil; Diabetes Mellitus, Type 2; Dietary Supplements; Fructosamine; Fructose; Glucose; Homeostasis; Inflammation; Liver; Metabolic Syndrome; Oxidative Stress; Rats; Rats, Wistar | 2023 |
Glycated Albumin Correlates With Time-in-Range Better Than HbA1c or Fructosamine.
Topics: Blood Glucose; Blood Glucose Self-Monitoring; Diabetes Mellitus, Type 2; Fructosamine; Glycated Hemoglobin; Glycated Serum Albumin; Glycation End Products, Advanced; Humans; Prospective Studies; Serum Albumin | 2023 |
Fructosamine as a predictor of incident diabetic microvascular disease in a population with high prevalence of red cell disorders: A cohort study.
Topics: Blood Glucose; Cohort Studies; Diabetes Mellitus, Type 2; Fructosamine; Glycated Hemoglobin; Hematologic Diseases; Humans; Prediabetic State; Prevalence; Retinal Diseases | 2023 |
Inverse association between 1,5-anhydroglucitol and neonatal diabetic complications.
Topics: Blood Glucose; Deoxyglucose; Diabetes Mellitus, Type 2; Diabetes, Gestational; Female; Fructosamine; Glycated Hemoglobin; Humans; Infant, Newborn; Infant, Newborn, Diseases; Pregnancy; Pregnancy in Diabetics; Prospective Studies; Risk Factors | 2019 |
Alterations of morphology and phosphorylated protein expression in the seminal vesicles of diabetic mice.
Topics: Animals; Citric Acid; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Fructosamine; Humans; Infertility, Male; Magnesium; Male; Mice; Mice, Inbred C57BL; Phosphorylation; Seminal Vesicles; Streptozocin; Tyrosine | 2019 |
Results of a Study Comparing Glycated Albumin to Other Glycemic Indices.
Topics: Biomarkers; Blood Glucose; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Follow-Up Studies; Fructosamine; Glycated Hemoglobin; Glycated Serum Albumin; Glycation End Products, Advanced; Glycemic Index; Humans; Hypoglycemic Agents; Male; Middle Aged; Prognosis; Prospective Studies; Serum Albumin | 2020 |
Glycaemic patterns in healthy elderly individuals and in those with impaired glucose metabolism - exploring the relationship with nonglycaemic variables.
Topics: Aged; Aged, 80 and over; Blood Glucose; C-Reactive Protein; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Female; Fructosamine; Glycated Hemoglobin; Homeostasis; Humans; Insulin Resistance; Male; Middle Aged; Prediabetic State; Regression Analysis; Switzerland; Triglycerides | 2019 |
Prevalence of low serum testosterone levels among men with type 2 diabetes mellitus attending two outpatient diabetes clinics in KwaZulu-Natal Province, South Africa.
Topics: Age Factors; Aged; Ambulatory Care Facilities; Body Mass Index; Case-Control Studies; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Fructosamine; Glycated Hemoglobin; Humans; Lipids; Luteinizing Hormone; Male; Metabolic Syndrome; Middle Aged; Prevalence; Risk Factors; Sex Hormone-Binding Globulin; South Africa; Surveys and Questionnaires; Symptom Assessment; Testosterone; Waist Circumference | 2019 |
Association of Glycated Proteins with Inflammatory Proteins and Periodontal Disease Parameters.
Topics: Adult; Chemokine CCL2; Diabetes Mellitus, Type 2; Female; Fibroblast Growth Factors; Fructosamine; Glycated Hemoglobin; Humans; Interleukin-10; Lymphotoxin-alpha; Male; Middle Aged; Periodontal Pocket; Periodontitis | 2020 |
Increased body fat mass reduces the association between fructosamine and glycated hemoglobin in obese type 2 diabetes patients.
Topics: Abdominal Fat; Aged; Diabetes Mellitus, Type 2; Female; Fructosamine; Glycated Hemoglobin; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Obesity; Prospective Studies | 2021 |
The ratio of estimated average glucose to fasting plasma glucose level as an indicator of insulin resistance in young adult diabetes: An observational study.
Topics: Adolescent; Adult; Blood Glucose; C-Peptide; Child; Diabetes Mellitus, Type 2; Fasting; Female; Fructosamine; Glycated Hemoglobin; Glycated Serum Albumin; Glycation End Products, Advanced; Glycemic Index; Humans; Insulin; Insulin Resistance; Male; Serum Albumin; Young Adult | 2020 |
Serum fructosamine and glycemic status in the presence of the sickle cell mutation.
Topics: Anemia, Sickle Cell; Diabetes Mellitus, Type 2; Fructosamine; Glycated Hemoglobin; Humans; Mutation | 2021 |
The glycemic status determines the direction of the relationship between red cell distribution width and HbA1c.
Topics: Blood Glucose; Case-Control Studies; Diabetes Mellitus, Type 2; Erythrocyte Indices; Fructosamine; Glycated Hemoglobin; Humans | 2021 |
Markers of Oxidative Stress and Antioxidant Defense in Romanian Patients with Type 2 Diabetes Mellitus and Obesity.
Topics: Adiponectin; Adiposity; Adult; Antioxidants; Biomarkers; Case-Control Studies; Diabetes Mellitus, Type 2; Female; Fructosamine; Glutathione; Glutathione Peroxidase; Glycated Hemoglobin; Humans; Insulin; Intra-Abdominal Fat; Male; Middle Aged; Obesity; Oxidative Stress; Respiratory Burst; Romania | 2017 |
Long-term obestatin treatment of mice type 2 diabetes increases insulin sensitivity and improves liver function.
Topics: 3-Hydroxybutyric Acid; Adenylate Kinase; Animals; Blood Glucose; Diabetes Mellitus, Type 2; Diet, High-Fat; Fructosamine; Ghrelin; Insulin; Insulin Resistance; Lipid Metabolism; Liver; Male; Mice; Mice, Inbred BALB C; Phosphorylation; Proto-Oncogene Proteins c-akt; Signal Transduction; Sirtuin 1; Treatment Outcome; Triglycerides | 2017 |
Synopsis of the 2017 U.S. Department of Veterans Affairs/U.S. Department of Defense Clinical Practice Guideline: Management of Type 2 Diabetes Mellitus.
Topics: Biomarkers; Blood Glucose; Clinical Decision-Making; Decision Making; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Fructosamine; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Life Expectancy; Patient Preference; Patient-Centered Care | 2017 |
Genome-Wide Association Study of Serum Fructosamine and Glycated Albumin in Adults Without Diagnosed Diabetes: Results From the Atherosclerosis Risk in Communities Study.
Topics: Adaptor Proteins, Signal Transducing; Adult; Atherosclerosis; Biomarkers; Black or African American; Calcium-Binding Proteins; Cohort Studies; Diabetes Mellitus, Type 2; Female; Fructosamine; Genetic Markers; Genetic Predisposition to Disease; Genetic Variation; Genome-Wide Association Study; Glycated Serum Albumin; Glycation End Products, Advanced; Humans; Male; Middle Aged; Mutation, Missense; Polymorphism, Single Nucleotide; Prospective Studies; Reproducibility of Results; Serum Albumin; United States; White People | 2018 |
Clinical implication of alterations in serum Klotho levels in patients with type 2 diabetes mellitus and its associated complications.
Topics: Adult; Aged; Biomarkers; Blood Glucose; Case-Control Studies; Diabetes Complications; Diabetes Mellitus, Type 2; Female; Fructosamine; Glucuronidase; Glycated Hemoglobin; Humans; Klotho Proteins; Male; Membrane Proteins; Middle Aged; Severity of Illness Index | 2018 |
2019 John Insall Award: Fructosamine is a better glycaemic marker compared with glycated haemoglobin (HbA1C) in predicting adverse outcomes following total knee arthroplasty: a prospective multicentre study.
Topics: Aged; Arthroplasty, Replacement, Knee; Biomarkers; Blood Glucose; Diabetes Mellitus, Type 2; Female; Follow-Up Studies; Fructosamine; Glycated Hemoglobin; Humans; Incidence; Male; Osteoarthritis, Knee; Postoperative Complications; Prognosis; Prospective Studies; United States | 2019 |
Glycosylated hemoglobin and albumin-corrected fructosamine are good indicators for glycemic control in peritoneal dialysis patients.
Topics: Aged; Blood Glucose; Diabetes Mellitus, Type 2; Dialysis Solutions; Extracellular Fluid; Female; Fructosamine; Glucans; Glucose; Glycated Hemoglobin; Glycated Serum Albumin; Glycation End Products, Advanced; Humans; Icodextrin; Kidney Failure, Chronic; Male; Middle Aged; Monitoring, Physiologic; Peritoneal Dialysis, Continuous Ambulatory; Serum Albumin | 2013 |
Testing infrared laser phototherapy (810 nm) to ameliorate diabetes: irradiation on body parts of diabetic mice.
Topics: Animals; Biomarkers; Blood Glucose; Diabetes Mellitus, Type 2; Female; Fructosamine; Infrared Rays; Lasers, Semiconductor; Low-Level Light Therapy; Male; Mice; Mice, Transgenic; Random Allocation; Torso; Treatment Outcome | 2013 |
Evaluation of glycemic variability in well-controlled type 2 diabetes mellitus.
Topics: Adolescent; Adult; Aged; Analysis of Variance; Area Under Curve; Biomarkers; Blood Glucose; Blood Glucose Self-Monitoring; Deoxyglucose; Diabetes Mellitus, Type 2; Female; Fructosamine; Glycated Hemoglobin; Humans; Hyperglycemia; Male; Mass Screening; Middle Aged; Predictive Value of Tests; Republic of Korea | 2013 |
Treatment with CNX-011-67, a novel GPR40 agonist, delays onset and progression of diabetes and improves beta cell preservation and function in male ZDF rats.
Topics: Animals; Blood Glucose; Carrier Proteins; Cell Cycle Proteins; Cell Line, Tumor; CHO Cells; Cricetinae; Cricetulus; Diabetes Mellitus, Type 2; Disease Progression; Drug Administration Schedule; Fatty Acids, Nonesterified; Fructosamine; Gene Expression; Glycated Hemoglobin; Homeodomain Proteins; Hypoglycemic Agents; Immunohistochemistry; Insulin; Insulin-Secreting Cells; Male; Pharmaceutical Preparations; Rats, Zucker; Receptors, G-Protein-Coupled; Reverse Transcriptase Polymerase Chain Reaction; Trans-Activators; Transcription Factor CHOP; Triglycerides | 2013 |
Use of complementary markers in assessing glycaemic control in people with diabetic kidney disease undergoing iron or erythropoietin treatment.
Topics: Administration, Intravenous; Aged; Biomarkers; Blood Glucose; Delivery of Health Care; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Epoetin Alfa; Erythropoietin; Female; Follow-Up Studies; Fructosamine; Glycated Hemoglobin; Glycated Serum Albumin; Glycation End Products, Advanced; Hematinics; Humans; Iron; Male; Monitoring, Physiologic; Prospective Studies; Recombinant Proteins; Renal Insufficiency, Chronic; Serum Albumin; Severity of Illness Index; Time Factors; Treatment Outcome | 2013 |
Pitfalls of glycated hemoglobin in the glycemic assessment of diabetes patients with hemoglobin louisville: role of serum fructosamine.
Topics: Aged; Blood Glucose; Diabetes Mellitus, Type 2; Female; Fructosamine; Glycated Hemoglobin; Hemoglobins, Abnormal; Humans; Hyperglycemia; Male; Middle Aged | 2013 |
Variables involved in the discordance between HbA1c and fructosamine: the glycation gap revisited.
Topics: Analysis of Variance; Creatinine; Diabetes Mellitus, Type 2; Fructosamine; Glycated Hemoglobin; Glycosylation; Humans; Hypoglycemic Agents; Logistic Models; Metformin; Spain | 2013 |
Association of glycation gap with mortality and vascular complications in diabetes.
Topics: Adult; Aged; Aged, 80 and over; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diabetic Retinopathy; Female; Fructosamine; Glycated Hemoglobin; Humans; Male; Middle Aged | 2013 |
Potential of birds to serve as pathology-free models of type 2 diabetes, part 2: do high levels of carbonyl-scavenging amino acids (e.g., taurine) and low concentrations of methylglyoxal limit the production of advanced glycation end-products?
Topics: Albumins; Animals; Arginine; Birds; Diabetes Mellitus, Type 2; Disease Models, Animal; Fructosamine; Glucose; Glycation End Products, Advanced; Lysine; Maillard Reaction; Pyruvaldehyde; Taurine | 2014 |
Clinicopathologic characteristics, prevalence, and risk factors of spontaneous diabetes in sooty mangabeys (Cercocebus atys).
Topics: Animals; Animals, Laboratory; Biomarkers; Body Weight; Cercocebus atys; Cholesterol; Diabetes Mellitus, Type 2; Female; Fructosamine; Glycated Hemoglobin; Islet Amyloid Polypeptide; Male; Monkey Diseases; Prediabetic State; Prevalence; Risk Factors; Triglycerides | 2014 |
The ratio of estimated average glucose to fasting plasma glucose level is superior to glycated albumin, hemoglobin A1c, fructosamine, and GA/A1c ratio for assessing β-cell function in childhood diabetes.
Topics: Adolescent; Adult; Blood Glucose; C-Peptide; Child; Child, Preschool; Diabetes Mellitus, Type 2; Fasting; Female; Fructosamine; Glucose; Glycated Hemoglobin; Glycated Serum Albumin; Glycation End Products, Advanced; Humans; Insulin; Insulin-Secreting Cells; Male; Serum Albumin; Young Adult | 2014 |
Serum fructosamine and risk of type 2 diabetes mellitus among middle-age Finnish men: a 23-year population-based prospective study.
Topics: Adult; Blood Glucose; C-Reactive Protein; Diabetes Mellitus, Type 2; Finland; Fructosamine; Humans; Lipoproteins, HDL; Male; Middle Aged; Prospective Studies | 2015 |
Falsely Decreased HbA1c in a Type 2 Diabetic Patient Treated with Dapsone.
Topics: Blood Glucose; Dapsone; Diabetes Mellitus, Type 2; Female; Fructosamine; Glycated Hemoglobin; Humans; Middle Aged | 2014 |
ISPAD Clinical Practice Consensus Guidelines 2014. Assessment and monitoring of glycemic control in children and adolescents with diabetes.
Topics: Adolescent; Adolescent Medicine; Blood Glucose Self-Monitoring; Child; Child, Preschool; Combined Modality Therapy; Diabetes Complications; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Evidence-Based Medicine; Fructosamine; Glycated Hemoglobin; Health Records, Personal; Humans; Hyperglycemia; Hypoglycemia; Infant; International Agencies; Ketone Bodies; Monitoring, Ambulatory; Pediatrics; Precision Medicine; Societies, Scientific | 2014 |
Poorly Regulated Blood Glucose in Diabetic Patients-predictor of Acute Infections.
Topics: Acute Disease; Adult; Age Factors; Aged; Blood Glucose; Bosnia and Herzegovina; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Fructosamine; Glycated Hemoglobin; Hospitalization; Humans; Male; Middle Aged; Prevalence; Respiratory Tract Infections; Sepsis; Urinary Tract Infections; Young Adult | 2014 |
Is skin autofluorescence a marker of metabolic memory in pregnant women with diabetes?
Topics: Adult; Biomarkers; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetes, Gestational; Female; Fluorescence; Forearm; France; Fructosamine; Glycated Hemoglobin; Glycation End Products, Advanced; Humans; Pregnancy; Pregnancy in Diabetics; Pregnancy Trimester, Second; Pregnancy Trimester, Third; Recurrence; Risk; Skin; Spectrometry, Fluorescence; Up-Regulation | 2015 |
Adipose Tissues Characteristics of Normal, Obesity, and Type 2 Diabetes in Uygurs Population.
Topics: Adipose Tissue; Adult; Asian People; Blood Glucose; Blood Pressure; Body Composition; Body Mass Index; China; Creatinine; Diabetes Mellitus, Type 2; Female; Fructosamine; Gene Expression Profiling; Humans; Intra-Abdominal Fat; Kazakhstan; Male; Middle Aged; Obesity; Real-Time Polymerase Chain Reaction; Tumor Necrosis Factor-alpha; Uric Acid | 2015 |
Markers of Glycemic Control and Neonatal Morbidity in High-Risk Insulin-Resistant Pregnancies.
Topics: Adult; Biomarkers; Blood Glucose; Cohort Studies; Diabetes Mellitus, Type 2; Diabetes, Gestational; Dystocia; Female; Fetal Macrosomia; Fructosamine; Glycated Hemoglobin; Humans; Hyperbilirubinemia, Neonatal; Hypoglycemia; Infant, Newborn; Infant, Newborn, Diseases; Insulin Resistance; Logistic Models; Male; Multivariate Analysis; Perinatal Death; Pregnancy; Pregnancy in Diabetics; Pregnancy, High-Risk; Prospective Studies; Respiratory Distress Syndrome, Newborn; Young Adult | 2016 |
Ethyl acetate fraction of Aframomum melegueta fruit ameliorates pancreatic β-cell dysfunction and major diabetes-related parameters in a type 2 diabetes model of rats.
Topics: Acetates; alpha-Amylases; alpha-Glucosidases; Animals; Blood Glucose; Creatine Kinase, MB Form; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Ethanol; Fructosamine; Fruit; Glycogen; Glycoside Hydrolase Inhibitors; Insulin; Insulin-Secreting Cells; L-Lactate Dehydrogenase; Lipids; Liver; Male; Plant Extracts; Rats, Sprague-Dawley; Solvents; Zingiberaceae | 2015 |
Gallic acid ameliorates hyperglycemia and improves hepatic carbohydrate metabolism in rats fed a high-fructose diet.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; C-Peptide; Carbohydrate Metabolism; Cell Line; Diabetes Mellitus, Type 2; Dietary Carbohydrates; Dietary Supplements; Fructosamine; Fructose; Gallic Acid; Gene Expression Regulation; Hepatitis; Hepatocytes; Hyperglycemia; Hypoglycemic Agents; Insulin Resistance; Male; Mice; Oxidative Stress; Rats, Wistar | 2016 |
The impact of intra-articular methylprednisolone acetate injection on fructosamine levels in diabetic patients with osteoarthritis of the knee, a case-control study.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Blood Glucose; C-Reactive Protein; Case-Control Studies; Diabetes Mellitus, Type 2; Female; Fructosamine; Glycated Hemoglobin; Humans; Injections, Intra-Articular; Israel; Linear Models; Male; Methylprednisolone; Methylprednisolone Acetate; Middle Aged; Multivariate Analysis; Osteoarthritis, Knee; Physical Therapy Modalities; Treatment Failure | 2016 |
[PREDICTORS OF MODERATE COGNITIVE DISORDERS IN PATIENTS WITH CORONARY HEART DISEASE AND TYPE 2 DIABETES MELLITUS].
Topics: Age Factors; Aged; Carbohydrate Metabolism; Cognition Disorders; Coronary Artery Disease; Diabetes Mellitus, Type 2; Educational Status; Fructosamine; Glycated Hemoglobin; Humans; Insulin; Lipid Metabolism; Male; Middle Aged; Predictive Value of Tests; Risk Factors; ROC Curve | 2016 |
Alternate glycemic markers reflect glycemic variability in continuous glucose monitoring in youth with prediabetes and type 2 diabetes.
Topics: Adolescent; Area Under Curve; Biomarkers; Blood Glucose; Child; Cohort Studies; Deoxyglucose; Diabetes Mellitus, Type 2; Female; Fructosamine; Glycated Hemoglobin; Glycated Serum Albumin; Glycation End Products, Advanced; Humans; Hyperglycemia; Hypoglycemia; Hypoglycemic Agents; Male; Monitoring, Ambulatory; Prediabetic State; Reproducibility of Results; Serum Albumin | 2017 |
Is Ramadan fasting safe in type 2 diabetic patients in view of the lack of significant effect of fasting on clinical and biochemical parameters, blood pressure, and glycemic control?
Topics: Blood Glucose; Blood Pressure; Body Mass Index; Body Weight; C-Peptide; Cholesterol, HDL; Diabetes Mellitus, Type 2; Fasting; Female; Fructosamine; Gliclazide; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Islam; Liver Function Tests; Male; Middle Aged; Morocco; Patient Education as Topic; Religion and Medicine; Risk Factors; Treatment Outcome; Triglycerides | 2008 |
Glargine insulin and high-protein-low-carbohydrate diet in cats with diabetes mellitus.
Topics: Animals; Animals, Domestic; Cat Diseases; Cats; Diabetes Mellitus, Type 2; Diet, Carbohydrate-Restricted; Diet, Diabetic; Fructosamine; Hypoglycemic Agents; Insulin; Insulin Glargine; Insulin, Long-Acting | 2008 |
Antihyperglycemic effect of stem bark powder from paper mulberry (Broussonetia kazinoki Sieb.) in type 2 diabetic Otsuka Long-Evans Tokushima fatty rats.
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Blood Glucose; Broussonetia; Diabetes Mellitus, Type 2; Fructosamine; Hyperglycemia; Hypoglycemic Agents; Insulin; Lipids; Morus; Phytotherapy; Plant Bark; Plant Stems; Powders; Rats; Rats, Inbred OLETF | 2008 |
Repaglinide plus single-dose insulin glargine: a safe regimen for low-risk type 2 diabetic patients who insist on fasting in Ramadan.
Topics: Adult; Aged; Blood Glucose; Blood Glucose Self-Monitoring; Blood Pressure; Carbamates; Diabetes Mellitus, Type 2; Drug Administration Schedule; Fasting; Female; Fructosamine; Humans; Hypoglycemia; Hypoglycemic Agents; Insulin; Insulin Glargine; Insulin, Long-Acting; Islam; Male; Middle Aged; Patient Selection; Piperidines; Risk Assessment; Safety; Turkey | 2009 |
Four weeks of near-normalisation of blood glucose improves the insulin response to glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide in patients with type 2 diabetes.
Topics: Adult; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Fasting; Fructosamine; Gastric Inhibitory Polypeptide; Glucagon-Like Peptide 1; Glycated Hemoglobin; Humans; Infusions, Intravenous; Insulin; Male; Middle Aged; Reference Values | 2009 |
The relationship between chronic glycaemic control and oxidative stress in type 2 diabetes mellitus.
Topics: Adult; Analysis of Variance; Biomarkers; Case-Control Studies; Diabetes Mellitus, Type 2; Female; Fructosamine; Glutathione Peroxidase; Glycated Hemoglobin; Glycemic Index; Humans; Hypoglycemic Agents; Insulin; Lipid Peroxidation; Male; Oxidative Stress; Selenium; Thiobarbituric Acid Reactive Substances; Time Factors; Vitamin E | 2008 |
Effect of hyperglycemia on mitochondrial respiration in type 2 diabetes.
Topics: Adult; Aged; Blood Glucose; Body Mass Index; Diabetes Mellitus, Type 2; Female; Fructosamine; Glycated Hemoglobin; Humans; Hyperglycemia; Hypoglycemic Agents; Insulin; Insulin Aspart; Insulin, Isophane; Male; Middle Aged; Mitochondria, Muscle; Muscle, Skeletal; Oxygen Consumption | 2009 |
Preferential recognition of Amadori-rich lysine residues by serum antibodies in diabetes mellitus: role of protein glycation in the disease process.
Topics: Adult; Animals; Antibodies; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Fructosamine; Furaldehyde; Glycosylation; Humans; Lysine; Male; Middle Aged; Polylysine; Rabbits | 2009 |
Glycaemic control in type 2 diabetic patients on chronic haemodialysis: use of a continuous glucose monitoring system.
Topics: Aged; Blood Glucose; Blood Glucose Self-Monitoring; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Fructosamine; Glycated Hemoglobin; Humans; Male; Middle Aged; Renal Dialysis | 2009 |
Protective effects of mildronate in an experimental model of type 2 diabetes in Goto-Kakizaki rats.
Topics: 3-Hydroxybutyric Acid; Administration, Oral; Animals; Blood Glucose; Cardiovascular Agents; Carnitine; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Disease Models, Animal; Fructosamine; Heart; Hyperalgesia; Hypoglycemic Agents; In Vitro Techniques; Lipids; Male; Methylhydrazines; Myocardial Ischemia; Pain Threshold; Rats; Rats, Wistar | 2009 |
A case of discordant HbA(1c): a method-dependent error.
Topics: Aged; Biomarkers; Blood Glucose; Blood Glucose Self-Monitoring; Chromatography, Ion Exchange; Diabetes Mellitus, Type 2; Fructosamine; Glycated Hemoglobin; Hemoglobins, Abnormal; Humans; Immunoassay; Male | 2009 |
Influence of fructose concentration on myocardial infarction in senile diabetic and non-diabetic patients.
Topics: Aged; Aging; Alzheimer Disease; Analysis of Variance; Antioxidants; Blood Glucose; Diabetes Mellitus, Type 2; Female; Fructosamine; Fructose; Humans; Male; Middle Aged; Myocardial Infarction; Oxidative Stress; Patient Selection | 2009 |
Variation in characteristics of islets of Langerhans in insulin-resistant, diabetic and non-diabetic-rat strains.
Topics: Animals; Blood Glucose; Cholesterol; Diabetes Mellitus, Type 2; Enzyme-Linked Immunosorbent Assay; Fatty Acids, Nonesterified; Fructosamine; Humans; Image Processing, Computer-Assisted; Immunohistochemistry; Insulin; Islets of Langerhans; Lactic Acid; Obesity; Rats; Rats, Wistar; Rats, Zucker; Triglycerides | 2010 |
Adiponectin SNP45TG is associated with gestational diabetes mellitus.
Topics: Adiponectin; Alleles; Body Mass Index; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Diabetes, Gestational; Female; Fructosamine; Gene Frequency; Genetic Carrier Screening; Genetic Predisposition to Disease; Genotype; Glucose Tolerance Test; Glycated Hemoglobin; Hemoglobinometry; Humans; Malaysia; Polymerase Chain Reaction; Polymorphism, Single Nucleotide; Pregnancy | 2011 |
Serum fructosamine versus glycosylated hemoglobin as an index of glycemic control, hospitalization, and infection in diabetic hemodialysis patients.
Topics: Adult; Aged; Aged, 80 and over; Blood Glucose; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Fructosamine; Glycated Hemoglobin; Hemodialysis Units, Hospital; Hospitalization; Humans; Infections; Kidney Failure, Chronic; Logistic Models; Male; Middle Aged; New York; Prospective Studies; Renal Dialysis; Urban Population | 2010 |
Effect of diabetes on enzymes involved in rat hepatic corticosterone production.
Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 1; Animals; Carbohydrate Dehydrogenases; Corticosterone; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Fructosamine; Hyperglycemia; Hypoglycemic Agents; Insulin; Isocitrate Dehydrogenase; Liver; Male; Microsomes, Liver; Rats; Rats, Sprague-Dawley; Weight Gain | 2010 |
Gaps in the glycation gap hypothesis.
Topics: Diabetes Mellitus, Type 2; Diabetic Nephropathies; Disease Progression; Fructosamine; Glycated Hemoglobin; Humans; Risk | 2011 |
Progression of nephropathy in type 2 diabetes: the glycation gap is a significant predictor after adjustment for glycohemoglobin (Hb A1c).
Topics: Diabetes Mellitus, Type 2; Diabetic Nephropathies; Disease Progression; Female; Follow-Up Studies; Fructosamine; Glycated Hemoglobin; Humans; Linear Models; Male; Middle Aged; Proportional Hazards Models | 2011 |
Glycaemic indices and non-traditional biochemical cardiovascular disease markers in a diabetic population in Nigeria.
Topics: Biomarkers; Blood Glucose; C-Reactive Protein; Cardiovascular Diseases; Chi-Square Distribution; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Female; Fibrinogens, Abnormal; Fructosamine; Glycated Hemoglobin; Humans; Lipoprotein(a); Male; Middle Aged; Nigeria; Risk Assessment; Statistics as Topic; Statistics, Nonparametric; Surveys and Questionnaires; Uric Acid | 2011 |
Assessment of markers of glycaemic control in diabetic patients with chronic kidney disease using continuous glucose monitoring.
Topics: Adult; Aged; Biomarkers; Blood Glucose; Case-Control Studies; Chronic Disease; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Fructosamine; Glycated Hemoglobin; Glycated Serum Albumin; Glycation End Products, Advanced; Humans; Hypoglycemic Agents; Male; Middle Aged; Monitoring, Physiologic; New Zealand; Peritoneal Dialysis; Regression Analysis; Renal Dialysis; Serum Albumin; Severity of Illness Index; Time Factors; Treatment Outcome | 2012 |
Platycodon grandiflorum modifies adipokines and the glucose uptake in high-fat diet in mice and L6 muscle cells.
Topics: Adipocytes; Adipokines; Adiponectin; Animals; Blood Glucose; Body Weight; Cell Line; Chromatography, High Pressure Liquid; Diabetes Mellitus, Type 2; Diet, High-Fat; Energy Intake; Fructosamine; Gene Expression; Glucose; Glucose Tolerance Test; Hypoglycemic Agents; Insulin; Leptin; Male; Mice; Mice, Inbred ICR; Muscle Cells; Obesity; Phytotherapy; Plant Extracts; Platycodon; Resistin; Saponins; Triglycerides; Triterpenes; Tumor Necrosis Factor-alpha | 2012 |
Increased 1,5-anhydroglucitol predicts glycemic remission in patients with newly diagnosed type 2 diabetes treated with short-term intensive insulin therapy.
Topics: Adult; Aged; Biomarkers; Blood Glucose; Deoxyglucose; Diabetes Mellitus, Type 2; Female; Follow-Up Studies; Fructosamine; Glucose Tolerance Test; Homeostasis; Humans; Hypoglycemic Agents; Insulin; Logistic Models; Longitudinal Studies; Male; Middle Aged; Odds Ratio; Predictive Value of Tests; Remission Induction; Time Factors | 2012 |
Analysis of serum activities of matrix metalloproteinases and α1-proteinase inhibitor in patients with type 2 diabetes mellitus.
Topics: Adult; Aged; alpha 1-Antitrypsin; Blood Glucose; C-Peptide; Case-Control Studies; Diabetes Mellitus, Type 2; Fructosamine; Humans; Matrix Metalloproteinase 2; Matrix Metalloproteinase 7; Middle Aged | 2012 |
Predicting outcomes and assessing control with alternate glycemic markers.
Topics: Blood Glucose; Deoxyglucose; Diabetes Mellitus, Type 2; Female; Fructosamine; Humans; Hypoglycemic Agents; Insulin; Male | 2012 |
Estimation of the glycation gap in diabetic patients with stable glycemic control.
Topics: Adult; Blood Glucose; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Fructosamine; Glycated Hemoglobin; Humans; Male; Middle Aged | 2012 |
The importance of L-arginine metabolism modulation in diabetic patients with distal symmetric polyneuropathy.
Topics: Aged; Arginase; Arginine; Blood Glucose; Chromatography, High Pressure Liquid; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Electrodiagnosis; Female; Fructosamine; Glycated Hemoglobin; Humans; Male; Methylation; Middle Aged; Nitrates; Nitrites; S-Nitrosothiols; Tyrosine | 2013 |
Glycation gap is associated with macroproteinuria but not with other complications in patients with type 2 diabetes.
Topics: Aged; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Fructosamine; Glycated Hemoglobin; Humans; Male; Middle Aged; Proteinuria | 2013 |
A comparison of fructosamine and HbA1c for home self-monitoring blood glucose levels in type 2 diabetes.
Topics: Adult; Aged; Blood Glucose; Blood Glucose Self-Monitoring; Diabetes Mellitus, Type 2; Female; Fructosamine; Glycated Hemoglobin; Humans; Male; Middle Aged; Prospective Studies | 2002 |
Therapeutic effects of psyllium in type 2 diabetic patients.
Topics: Aged; Blood Glucose; C-Peptide; Cholesterol; Diabetes Mellitus, Type 2; Female; Fructosamine; Glycated Hemoglobin; Glycosuria; Humans; Insulin; Male; Middle Aged; Minerals; Psyllium; Time Factors; Vitamins | 2002 |
Effective use of thiazolidinediones for the treatment of glucocorticoid-induced diabetes.
Topics: Administration, Oral; Adult; Biomarkers; Blood Glucose; Chromans; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Fructosamine; Glucocorticoids; Glucose Tolerance Test; Humans; Hypoglycemic Agents; Insulin; Leptin; Middle Aged; Prednisone; Thiazoles; Thiazolidinediones; Troglitazone | 2002 |
Home fructosamine testing: is its demise premature?
Topics: Blood Glucose Self-Monitoring; Diabetes Mellitus, Type 2; Fructosamine; Humans; Randomized Controlled Trials as Topic; Reproducibility of Results; Research Design | 2002 |
Metabolic and cardiovascular effects of very-low-calorie diet therapy in obese patients with Type 2 diabetes in secondary failure: outcomes after 1 year.
Topics: Adult; Aged; Blood Glucose; Blood Pressure; Body Mass Index; Cardiovascular Diseases; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diet, Reducing; Female; Fructosamine; Humans; Male; Middle Aged; Obesity; Time Factors; Treatment Outcome | 2003 |
Effect of soluble dietary fibre fraction of Trigonella foenum graecum on glycemic, insulinemic, lipidemic and platelet aggregation status of Type 2 diabetic model rats.
Topics: Administration, Oral; Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dietary Fiber; Drug Administration Schedule; Fructosamine; Hypoglycemic Agents; India; Insulin; Lipid Metabolism; Lipids; Male; Plant Extracts; Platelet Aggregation; Rats; Rats, Long-Evans; Seeds; Time Factors; Trigonella | 2003 |
Changes in glycosylated proteins in diabetic and non-diabetic patients with and without cardiovascular complications.
Topics: Blood Glucose; Blood Proteins; Cardiovascular Diseases; Case-Control Studies; Diabetes Mellitus, Type 2; Fasting; Female; Fructosamine; Glycated Hemoglobin; Glycoproteins; Glycosylation; Hexosamines; Humans; Male; Middle Aged; Pakistan; Sialic Acids | 2003 |
The role of adenosine triphosphate citrate lyase in the metabolism of acetyl coenzyme a and function of blood platelets in diabetes mellitus.
Topics: Acetyl Coenzyme A; Adult; ATP Citrate (pro-S)-Lyase; Blood Glucose; Blood Platelets; Citrates; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Enzyme Inhibitors; Fructosamine; Glycated Hemoglobin; Humans; Lactones; Malondialdehyde; Middle Aged; Platelet Activation; Platelet Aggregation; Pyruvate Dehydrogenase Complex; Thrombin | 2004 |
A prospective study of glycemic control during holiday time in type 2 diabetic patients.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Blood Glucose; Blood Pressure; China; Diabetes Mellitus, Type 2; Female; Fructosamine; Glycated Hemoglobin; Holidays; Humans; Male; Middle Aged; Pulse; Self Care | 2004 |
The effect of glycemic control in type 2 diabetic patients with diabetes-related dyslipidemia.
Topics: Adult; Aged; Analysis of Variance; Blood Glucose; Diabetes Mellitus, Type 2; Female; Fructosamine; Humans; Hyperlipidemias; Male; Middle Aged; Regression Analysis; Saudi Arabia | 2004 |
Insulin sensitivity in the offspring of women with type 1 and type 2 diabetes.
Topics: Adipose Tissue; Adult; Birth Weight; Blood Glucose; Body Mass Index; Child; Child of Impaired Parents; Child, Preschool; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Fructosamine; Glucose Tolerance Test; Humans; Hypoglycemic Agents; Infant, Newborn; Infusions, Intravenous; Insulin; Insulin, Regular, Pork; Male; Pregnancy; Reference Values | 2004 |
Partial androgen deficiency in aging type 2 diabetic men and its relationship to glycemic control.
Topics: Adult; Aged; Aged, 80 and over; Aging; Androgens; Blood Glucose; C-Peptide; Case-Control Studies; Diabetes Mellitus, Type 2; Fasting; Fructosamine; Glycated Hemoglobin; Gonadotropins; Gonadotropins, Pituitary; Humans; Insulin; Male; Middle Aged; Testosterone; Time Factors; Treatment Outcome | 2004 |
[Effect of ACE gene polymorphism on carbohydrate metabolism, on oxidative stress and on end-organ damage in type-2 diabetes mellitus].
Topics: Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Blood Glucose; Blood Pressure; Carbohydrate Metabolism; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Female; Fructosamine; Gene Deletion; Humans; Hypertension; Hypertension, Renovascular; Hypoglycemic Agents; Insulin; Kidney Function Tests; Male; Middle Aged; Mutagenesis, Insertional; Oxidative Stress; Peptidyl-Dipeptidase A; Polymorphism, Genetic | 2004 |
Lipid peroxidation and resistance to oxidation in patients with type 2 diabetes mellitus.
Topics: Adult; Antioxidants; Blood Glucose; Cholesterol; Diabetes Mellitus, Type 2; Erythrocytes; Female; Fructosamine; Glutathione; Hemoglobins; Humans; Lipid Peroxidation; Male; Malondialdehyde; Middle Aged; Oxidants; Oxygen; Sulfhydryl Compounds; Triglycerides; Uric Acid | 2004 |
Non-enzymatic glycosylation of immunoglobulins in diabetic nephropathy.
Topics: Adolescent; Adult; Aged; Carbohydrates; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Fructosamine; Glycated Hemoglobin; Glycosylation; Humans; Immunoglobulin A; Immunoglobulin G; Immunoglobulin M; Immunoglobulins; Male; Middle Aged; Regression Analysis | 2004 |
Plasma albumin concentration is a predictor of HbA1c among type 2 diabetic patients, independently of fasting plasma glucose and fructosamine.
Topics: Blood Glucose; Creatinine; Diabetes Mellitus, Type 2; Fasting; Fructosamine; Globulins; Glycated Hemoglobin; Humans; Predictive Value of Tests; Regression Analysis; Serum Albumin | 2005 |
[Comparative analysis of dependence of saliva sorbitol and fructosamine levels on blood glucose level in patients with diabetes].
Topics: Adult; Aged; Biomarkers; Blood Glucose; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Fructosamine; Humans; Male; Middle Aged; Saliva; Sorbitol | 2004 |
Glycemic monitoring in diabetics with sickle cell plus beta-thalassemia hemoglobinopathy.
Topics: Anemia, Sickle Cell; beta-Thalassemia; Blood Glucose; Blood Glucose Self-Monitoring; Diabetes Mellitus, Type 2; Female; Fructosamine; Glycated Hemoglobin; Humans; Middle Aged | 2005 |
Anthropometric characteristics, dietary patterns and risk of type 2 diabetes mellitus in Vietnam.
Topics: Adipose Tissue; Blood Glucose; Body Composition; Body Constitution; Body Mass Index; Case-Control Studies; Diabetes Mellitus, Type 2; Dietary Proteins; Feeding Behavior; Female; Fructosamine; Humans; Life Style; Lipids; Male; Middle Aged; Risk Factors; Social Class; Vietnam; Waist-Hip Ratio | 2005 |
Left ventricular dysfunction in hypertensive patients with Type 2 diabetes mellitus.
Topics: Blood Flow Velocity; Blood Glucose; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Diabetes Mellitus, Type 2; Diastole; Echocardiography; Female; Fructosamine; Glycated Hemoglobin; Heart Ventricles; Humans; Hypertension; Male; Middle Aged; Systole; Ventricular Dysfunction, Left | 2005 |
Serum uric acid concentrations in type 2 diabetes: its significant relationship to serum 1,5-anhydroglucitol concentrations.
Topics: Adult; Aged; Blood Glucose; Body Mass Index; Cholesterol; Creatinine; Deoxyglucose; Diabetes Mellitus, Type 2; Fasting; Female; Fructosamine; Glycated Hemoglobin; Humans; Linear Models; Male; Middle Aged; Sex Characteristics; Uric Acid | 2005 |
[Ramadan fasting in type 2 diabetes mellitus].
Topics: Adult; Blood Glucose; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Diabetes Mellitus, Type 2; Fasting; Female; Fructosamine; Glycated Hemoglobin; Humans; Islam; Male; Middle Aged; Triglycerides; Weight Loss | 2006 |
Correlation between fasting plasma glucose, post prandial glucose and glycated haemoglobin and fructosamine.
Topics: Adult; Aged; Blood Glucose; Diabetes Mellitus, Type 2; Fasting; Female; Fructosamine; Glycated Hemoglobin; Humans; Male; Middle Aged; Postprandial Period; Prospective Studies | 2006 |
1,5-anhydroglucitol and postprandial hyperglycemia as measured by continuous glucose monitoring system in moderately controlled patients with diabetes.
Topics: Deoxyglucose; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Fructosamine; Glycated Hemoglobin; Humans; Hyperglycemia; Monitoring, Ambulatory; Monitoring, Physiologic; Postprandial Period; Reproducibility of Results | 2006 |
Serum fructosamine in the assessment of glycaemic status in patients with sickle cell anaemia.
Topics: Adolescent; Adult; Anemia, Sickle Cell; Bilirubin; Blood Glucose; Diabetes Mellitus, Type 2; Female; Fructosamine; Humans; Male; Middle Aged; Serum Albumin | 2006 |
A comparison of glycemic effects of glimepiride, repaglinide, and insulin glargine in type 2 diabetes mellitus during Ramadan fasting.
Topics: Adult; Body Mass Index; Carbamates; Diabetes Mellitus, Type 2; Fasting; Female; Fructosamine; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Insulin Glargine; Insulin, Long-Acting; Islam; Male; Middle Aged; Patient Selection; Piperidines; Sulfonylurea Compounds; Turkey | 2007 |
Influence of clinical factors on blue-on-yellow perimetry for diabetic patients without retinopathy: comparison with white-on-white perimetry.
Topics: Adult; Blood Glucose; Diabetes Mellitus, Type 2; Female; Fructosamine; Glycated Hemoglobin; Humans; Male; Middle Aged; Retinal Cone Photoreceptor Cells; Rod Opsins; Visual Field Tests; Visual Fields | 2006 |
Decrease of fructosamine levels during treatment with adalimumab in patients with both diabetes and rheumatoid arthritis.
Topics: Adalimumab; Adult; Aged; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Arthritis, Rheumatoid; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Fructosamine; Humans; Male; Tumor Necrosis Factor-alpha | 2007 |
Diabetic foot patients with and without retinopathy and plasma oxidative stress.
Topics: Acute-Phase Proteins; Biomarkers; Case-Control Studies; Diabetes Mellitus, Type 2; Diabetic Foot; Diabetic Retinopathy; Female; Fructosamine; Glycated Hemoglobin; Humans; Male; Middle Aged; Oxidative Stress; Uric Acid | 2007 |
Bioelectrical impedance analysis and diabetes mellitus: which correlation among fructosamine, glycosylated haemoglobin and exchangeable potassium.
Topics: Adolescent; Adult; Aged; Body Composition; Body Water; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Electric Impedance; Female; Fructosamine; Glycated Hemoglobin; Humans; Male; Middle Aged; Potassium | 2007 |
Glycosylation of hair: possible measure of chronic hyperglycaemia.
Topics: Adolescent; Adult; Chronic Disease; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Fructosamine; Glycated Hemoglobin; Hair; Hexosamines; Humans; Hyperglycemia; Male; Middle Aged | 1984 |
Serum fructosamine concentrations in patients with type II (non-insulin-dependent) diabetes mellitus during changes in management.
Topics: Adult; Aged; Blood Glucose; Diabetes Mellitus, Type 2; Female; Fructosamine; Glycated Hemoglobin; Glycosuria; Hexosamines; Humans; Male; Middle Aged; Time Factors | 1984 |
Kinetics of HbA1c, glycated albumin, and fructosamine and analysis of their weight functions against preceding plasma glucose level.
Topics: Adult; Analysis of Variance; Blood Glucose; Diabetes Mellitus, Type 2; Female; Fructosamine; Glycated Hemoglobin; Glycated Serum Albumin; Glycation End Products, Advanced; Glycosylation; Hexosamines; Humans; Male; Mathematics; Middle Aged; Serum Albumin | 1995 |
Diabetes care in South Asian and white European patients with type 2 diabetes.
Topics: Asia; Biomarkers; Body Mass Index; Caribbean Region; Case-Control Studies; Diabetes Mellitus, Type 2; Diet, Diabetic; Female; Fructosamine; Hexosamines; Humans; Hypoglycemic Agents; Insulin; Male; Middle Aged; Racial Groups; Sex Characteristics; United Kingdom; White People | 1995 |
Similar insulin sensitivity in NIDDM patients with normo- and microalbuminuria.
Topics: Albuminuria; Blood Glucose; Body Composition; C-Peptide; Calorimetry; Circadian Rhythm; Diabetes Mellitus, Type 2; Diastole; Female; Fructosamine; Glucose; Glucose Clamp Technique; Glycated Hemoglobin; Glycolysis; Heart Rate; Hexosamines; Humans; Infusions, Intravenous; Insulin; Insulin Resistance; Male; Middle Aged; Oxidation-Reduction; Reference Values; Regression Analysis; Systole; Tritium | 1995 |
Metabolic control quality and free radical activity in diabetic patients.
Topics: Adolescent; Adult; Aged; Biomarkers; Blood Glucose; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Free Radicals; Fructosamine; Hexosamines; Humans; Hydrogen Peroxide; Insulin; Male; Malondialdehyde; Middle Aged; Oxidation-Reduction; Reference Values; Time Factors | 1995 |
Improved metabolic control in patients with non-insulin-dependent diabetes mellitus is associated with a slower accumulation of glycation products in collagen.
Topics: Adult; Aged; Blood Glucose; Blood Glucose Self-Monitoring; Collagen; Diabetes Mellitus, Type 2; Fasting; Female; Follow-Up Studies; Fructosamine; Glycated Hemoglobin; Hexosamines; Humans; Hypoglycemic Agents; Insulin; Male; Middle Aged; Patient Education as Topic; Platelet Activating Factor; Regression Analysis; Time Factors | 1995 |
Lipoprotein(a), apolipoprotein(a) polymorphism, and insulin treatment in type II diabetic patients.
Topics: Administration, Oral; Apolipoproteins; Apoprotein(a); Blood Glucose; Blood Pressure; Cholesterol; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Fructosamine; Glycated Hemoglobin; Hexosamines; Humans; Hypertension; Hypoglycemic Agents; Insulin; Lipoprotein(a); Male; Middle Aged; Molecular Weight; Polymorphism, Genetic; Triglycerides | 1995 |
Vascular complications of patients in Kuwait with type 2 diabetes mellitus (NIDDM) and elevated serum lipid peroxides.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Blood Glucose; Body Mass Index; Cholesterol; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Diabetic Retinopathy; Female; Fructosamine; Glycated Hemoglobin; Hexosamines; Humans; Kuwait; Lipid Peroxides; Male; Middle Aged; Probability; Sensitivity and Specificity; Triglycerides | 1994 |
[Role of the determination of serum fructosamine in the screening of glucose intolerance].
Topics: Adult; Diabetes Mellitus; Diabetes Mellitus, Type 2; Fructosamine; Glucose Intolerance; Glucose Tolerance Test; Hexosamines; Humans; Mass Screening; Middle Aged; Obesity | 1994 |
[Prevalence estimates for non-insulin dependent diabetes mellitus (NIDDM) in Japan from National Survey of Circulatory Disorders 1990 data].
Topics: Adult; Aged; Aged, 80 and over; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Female; Fructosamine; Glycated Hemoglobin; Health Surveys; Hexosamines; Humans; Japan; Male; Middle Aged; National Health Programs; Prevalence | 1994 |
Thiobarbiturate and fructosamine assays: significance and interest of the borohydride blank.
Topics: Acute-Phase Reaction; Adolescent; Adult; Aged; Aged, 80 and over; Blood Glucose; Borohydrides; C-Reactive Protein; Colorimetry; Diabetes Mellitus, Type 2; Fructosamine; Glycoproteins; Glycosylation; Hexosamines; Humans; Middle Aged; Thiobarbiturates | 1994 |
Low-density lipoprotein particle size in type 2 diabetic patients and age matched controls.
Topics: Adult; Aged; Aged, 80 and over; Blood Glucose; Chromatography, Affinity; Diabetes Mellitus, Type 2; Fructosamine; Glycosylation; Hemoglobin A; Hexosamines; Humans; Lipoproteins, LDL; Male; Middle Aged; Particle Size; Triglycerides; Ultracentrifugation | 1994 |
Fluorescence-determined kinetics of plasma high oxidability in diabetic patients.
Topics: Aged; Blood Glucose; Diabetes Mellitus, Type 2; Fluorescence; Fructosamine; Glycated Hemoglobin; Hexosamines; Humans; Kinetics; Lipid Peroxidation; Middle Aged; Thiobarbituric Acid Reactive Substances | 1994 |
Fructosamine: an alternative assessment of past glycaemic control in developing countries.
Topics: Blood Glucose; Developing Countries; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Fructosamine; Glycated Hemoglobin; Hexosamines; Humans; Pakistan; Reagent Kits, Diagnostic; Reference Values | 1993 |
Accelerated cholesteryl ester transfer in noninsulin-dependent diabetes mellitus.
Topics: Carrier Proteins; Cholesterol; Cholesterol Ester Transfer Proteins; Cholesterol Esters; Cholesterol, HDL; Diabetes Mellitus, Type 2; Female; Fructosamine; Glycoproteins; Hexosamines; Humans; Male; Middle Aged; Triglycerides | 1993 |
Atrial natriuretic factor in hypertensive and normotensive diabetic patients.
Topics: Adult; Analysis of Variance; Atrial Natriuretic Factor; Blood Glucose; Blood Pressure; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Fasting; Female; Fructosamine; Hexosamines; Humans; Hypertension; Insulin; Male; Middle Aged; Posture; Potassium; Reference Values; Sodium | 1994 |
Fetal liver length in diabetic pregnancy.
Topics: Adult; Blood Glucose; Case-Control Studies; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Embryonic and Fetal Development; Female; Fetus; Fructosamine; Hexosamines; Humans; Liver; Obesity; Pregnancy; Pregnancy Complications; Pregnancy in Diabetics; Ultrasonography, Prenatal | 1994 |
Glycated immunoglobulin M in diabetic patients.
Topics: Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Fructosamine; Glycated Hemoglobin; Glycation End Products, Advanced; Hexosamines; Humans; Immunoglobulin M; Male; Middle Aged; Reference Values | 1993 |
The size of the pancreas in diabetes mellitus.
Topics: Adolescent; Adult; Aged; Biomarkers; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Fructosamine; Hexosamines; Humans; Male; Middle Aged; Pancreas; Reference Values; Ultrasonography | 1993 |
Renal uric acid handling in non-insulin-dependent diabetic patients with elevated glomerular filtration rates.
Topics: Creatinine; Diabetes Mellitus, Type 2; Female; Fructosamine; Glomerular Filtration Rate; Hexosamines; Humans; Kidney; Male; Middle Aged; Uric Acid | 1993 |
Selective determination of non-enzymatic glycosylated serum albumin as a medium term index of diabetic control.
Topics: Adult; Aged; Biomarkers; Blood Glucose; Blood Proteins; Chromatography, Affinity; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Fructosamine; Glycated Hemoglobin; Glycated Serum Albumin; Glycated Serum Proteins; Glycation End Products, Advanced; Glycoproteins; Glycosylation; Hexosamines; Humans; Male; Middle Aged; Serum Albumin | 1993 |
[Correlations of the levels of HbA1c with plasma apoproteins and plasma lipoproteins in type II diabetic patients].
Topics: Apolipoproteins; Blood Glucose; Diabetes Mellitus, Type 2; Fructosamine; Glycated Hemoglobin; Hexosamines; Humans; Lipoproteins; Male; Middle Aged | 1993 |
Elevated serum sialic acid concentration in NIDDM and its relationship to blood pressure and retinopathy.
Topics: Albuminuria; Biomarkers; Blood Glucose; Blood Pressure; Body Mass Index; Cholesterol; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Female; Fructosamine; Hexosamines; Humans; Male; Middle Aged; N-Acetylneuraminic Acid; Reference Values; Sialic Acids; Triglycerides | 1993 |
Plasma lipoprotein (a) concentration and phenotypes in diabetes mellitus.
Topics: Adult; Apolipoprotein A-I; Apolipoproteins B; Austria; Blood Glucose; Cholesterol; Cholesterol, HDL; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Fructosamine; Glycated Hemoglobin; Hexosamines; Humans; Hungary; Lipoprotein(a); Male; Middle Aged; Phenotype; Regression Analysis; Triglycerides | 1993 |
Fructosamine as a possible monitoring parameter in non-insulin dependent diabetes mellitus patients with periodontal disease.
Topics: Blood Glucose; Dental Care for Disabled; Dental Plaque Index; Diabetes Mellitus, Type 2; Female; Fructosamine; Hexosamines; Humans; Male; Middle Aged; Periodontal Index; Periodontitis; Time Factors | 1993 |
A diabetic case of Hb Riyadh with a low HbA1c value.
Topics: Aged; Biomarkers; Blood Glucose; Chromatography, High Pressure Liquid; Diabetes Mellitus, Type 2; Fructosamine; Glycated Hemoglobin; Hemoglobins, Abnormal; Hexosamines; Humans; Isoelectric Focusing; Male | 1993 |
Diabetes mellitus and employment: survey of a New Zealand workforce.
Topics: Adult; Biomarkers; Blood Glucose; Cholesterol, HDL; Cross-Sectional Studies; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Employment; Ethnicity; Female; Fructosamine; Health Status; Hexosamines; Humans; Male; Middle Aged; New Zealand; Prevalence; Reference Values; Triglycerides | 1993 |
Recombinant human insulin-like growth factor I increases insulin sensitivity and improves glycemic control in type II diabetes.
Topics: Adult; Blood Glucose; Body Composition; Diabetes Mellitus, Type 2; Female; Fructosamine; Glucose Tolerance Test; Glycated Hemoglobin; Hexosamines; Humans; Injections, Subcutaneous; Insulin; Insulin Resistance; Insulin-Like Growth Factor Binding Proteins; Insulin-Like Growth Factor I; Lipids; Male; Middle Aged; Recombinant Proteins | 1996 |
Glycation of lipoproteins and accelerated atherosclerosis in non-insulin-dependent diabetes mellitus.
Topics: Albumins; Arteriosclerosis; Blood Glucose; Cholesterol, HDL; Cholesterol, LDL; Cholesterol, VLDL; Diabetes Mellitus, Type 2; Female; Fructosamine; Glycated Hemoglobin; Glycosylation; Hexosamines; Humans; Lipoproteins; Male; Predictive Value of Tests; Triglycerides | 1995 |
Plasma and urine malondialdehyde levels in non-insulin-dependent diabetic patients with and without microalbuminuria.
Topics: Adult; Aged; Albuminuria; Blood Glucose; Cholesterol, HDL; Cholesterol, LDL; Cholesterol, VLDL; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Fructosamine; Hexosamines; Humans; Lipid Peroxidation; Male; Malondialdehyde; Middle Aged; Time Factors; Triglycerides | 1995 |
Long-term assessment of glucose control by haemoglobin-AGE measurement.
Topics: Blood Glucose; Diabetes Mellitus, Type 2; Erythrocytes; Female; Fructosamine; Glycated Hemoglobin; Glycation End Products, Advanced; Hexosamines; Humans; Hypoglycemic Agents; Insulin; Male; Middle Aged | 1996 |
Current state of metabolic control achieved in a New Zealand diabetes clinic.
Topics: Adult; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Fasting; Female; Fructosamine; Hexosamines; Humans; Lipids; Male; Middle Aged; New Zealand; Regression Analysis; Smoking | 1996 |
Glycosylated hemoglobin and fructosamines: does their determination really reflect the glycemic control in diabetic patients?
Topics: Aged; Blood Glucose; Diabetes Mellitus, Type 2; Fasting; Female; Fructosamine; Glycated Hemoglobin; Hexosamines; Humans; Male; Middle Aged | 1996 |
[The effect of fish oil on metabolic parameters in patients with type 2 diabetes mellitus associated with dyslipidemia].
Topics: Blood Glucose; Diabetes Mellitus, Type 2; Fatty Acids, Omega-3; Female; Fructosamine; Hexosamines; Humans; Hyperlipidemias; Insulin; Lipids; Male; Middle Aged | 1996 |
Plasma fibrinogen in NIDDM: the Rotterdam study.
Topics: Age Factors; Aged; Body Mass Index; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Female; Fibrinogen; Fructosamine; Hexosamines; Humans; Hypertension; Hypoglycemic Agents; Insulin; Male; Middle Aged; Netherlands; Reference Values; Sex Characteristics; Sex Factors; Smoking | 1996 |
The effects of ageing on glycation and the interpretation of glycaemic control in Type 2 diabetes.
Topics: Adult; Aged; Aging; Blood Glucose; Diabetes Mellitus, Type 2; Female; Fructosamine; Glycated Hemoglobin; Glycosylation; Hexosamines; Humans; Male; Middle Aged; Statistics, Nonparametric | 1996 |
Serum lipoprotein-a levels and glyco-metabolic control in insulin and non-insulin dependent diabetes mellitus.
Topics: Adult; Aged; Albuminuria; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Diabetic Retinopathy; Female; Fructosamine; Hemoglobins; Humans; Lipoprotein(a); Male; Middle Aged | 1996 |
Serum glycated lipoproteins in type II diabetic patients with and without complications.
Topics: Cholesterol; Diabetes Mellitus, Type 2; Electrophoresis, Agar Gel; Female; Fructosamine; Glycated Serum Albumin; Glycation End Products, Advanced; Glycosylation; Hexosamines; Humans; Lipoproteins; Lipoproteins, LDL; Lipoproteins, VLDL; Male; Middle Aged; Serum Albumin; Triglycerides | 1995 |
Neutrophil bactericidal function in diabetes mellitus: evidence for association with blood glucose control.
Topics: Adult; Aged; Biomarkers; Blood Bactericidal Activity; Blood Glucose; Case-Control Studies; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Fructosamine; Glycated Hemoglobin; Hexosamines; Humans; Luminescent Measurements; Middle Aged; Neutrophils; Reference Values; Statistics, Nonparametric | 1995 |
Relationship of oxidative stress and fibrinolysis in diabetes mellitus.
Topics: Adult; Body Mass Index; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Erythrocytes; Female; Fibrinolysis; Fructosamine; Humans; Male; Malondialdehyde; Middle Aged; Oxidative Stress; Plasminogen Activator Inhibitor 1; Reference Values; Regression Analysis; Superoxide Dismutase; Tissue Plasminogen Activator | 1996 |
Peripheral somatic nerve function in relation to glucose tolerance in an elderly Caucasian population: the Hoorn study.
Topics: Aged; Ankle Joint; Blood Glucose; Cohort Studies; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Discrimination, Psychological; Female; Fructosamine; Glucose Intolerance; Glucose Tolerance Test; Glycated Hemoglobin; Humans; Insulin; Knee Joint; Male; Middle Aged; Netherlands; Odds Ratio; Peripheral Nerves; Reflex; Sensory Thresholds; Toes; Vibration; White People | 1996 |
Effect of acarbose on blood glucose profiles and plasma 1,5-anhydro-d-glucitol in type 2 diabetes poorly controlled by sulfonylurea therapy.
Topics: Acarbose; Aged; Blood Glucose; Deoxyglucose; Diabetes Mellitus, Type 2; Female; Fructosamine; Glucose Tolerance Test; Glyburide; Glycosuria; Humans; Hypoglycemic Agents; Lipids; Male; Middle Aged; Trisaccharides | 1996 |
Vitamin A (retinol) status of first nation adults with non-insulin-dependent diabetes mellitus.
Topics: Alberta; Blood Glucose; Cohort Studies; Diabetes Mellitus, Type 2; Female; Fructosamine; Humans; Indians, North American; Insulin; Linear Models; Male; Middle Aged; Prealbumin; Retinol-Binding Proteins; Retinol-Binding Proteins, Plasma; Triglycerides; Vitamin A; Vitamin E; Zinc | 1997 |
Daily activity level buffers stress-glycemia associations in older sedentary NIDDM patients.
Topics: Activities of Daily Living; Aged; Anxiety; Blood Glucose; Depression; Diabetes Mellitus, Type 2; Female; Fructosamine; Glycated Hemoglobin; Health Knowledge, Attitudes, Practice; Humans; Male; Patient Compliance; Stress, Psychological | 1997 |
Formation of plasma advanced glycosylation end products (AGEs) has no influence on plasma viscosity.
Topics: Adult; Blood Proteins; Blood Viscosity; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Fructosamine; Glycated Hemoglobin; Glycation End Products, Advanced; Humans; Male; Reference Values; Regression Analysis; Rheology | 1997 |
Clinical and serological responses to an inactivated influenza vaccine in adults with HIV infection, diabetes, obstructive airways disease, elderly adults and healthy volunteers.
Topics: Adult; Aged; Airway Obstruction; Antibodies, Viral; beta 2-Microglobulin; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Fructosamine; HIV Infections; Humans; Influenza Vaccines; Lymphocyte Count; Male; Middle Aged; Peak Expiratory Flow Rate; Vaccines, Inactivated; Volunteers | 1997 |
Decreased activity of arachidonate 12-lipoxygenase in platelets of Japanese patients with non-insulin-dependent diabetes mellitus.
Topics: Adult; Aged; Arachidonate 12-Lipoxygenase; Arachidonic Acid; Blood Glucose; Blood Platelets; Body Mass Index; Cytosol; Deoxyglucose; Diabetes Mellitus, Type 2; Female; Fructosamine; Fructose; Glucose; Glycated Hemoglobin; Humans; Male; Middle Aged; Sex Characteristics | 1998 |
Oxidative damage, plasma antioxidant capacity, and glucemic control in elderly NIDDM patients.
Topics: Adult; Aged; Antioxidants; Blood Glucose; Diabetes Mellitus, Type 2; Erythrocytes; Fasting; Fructosamine; Humans; Lipid Peroxidation; Lipids; Male; Middle Aged; Oxidative Stress; Peroxides; tert-Butylhydroperoxide; Uric Acid | 1998 |
[Glycosylation and lipid peroxidation in skin and in plasma in diabetic patients].
Topics: Aged; Aged, 80 and over; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Female; Fructosamine; Glycation End Products, Advanced; Glycosylation; Humans; Lipid Peroxidation; Male; Malondialdehyde; Middle Aged; Skin; Thiobarbituric Acid Reactive Substances | 1997 |
Comparison of serum fructosamine vs glycohemoglobin as measures of glycemic control in a large diabetic population.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Blood Glucose; Child; Child, Preschool; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetes, Gestational; Female; Forecasting; Fructosamine; Glycated Hemoglobin; Humans; Male; Middle Aged; Pregnancy; ROC Curve | 1998 |
Urinary albumin excretion rate and glomerular filtration rate in single-kidney type 2 diabetic patients.
Topics: Adult; Albuminuria; Blood Glucose; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Female; Fructosamine; Glomerular Filtration Rate; Humans; Kidney; Male; Middle Aged | 1998 |
Electronegative low density lipoprotein subform (LDL-) is increased in type 2 (non-insulin-dependent) microalbuminuric diabetic patients and is closely associated with LDL susceptibility to oxidation.
Topics: Aged; Albuminuria; Blood Pressure; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Diabetes Mellitus, Type 2; Female; Fructosamine; Humans; Lipoproteins, LDL; Male; Middle Aged; Oxidation-Reduction; Reference Values; Triglycerides | 1998 |
The use of Acarbose in Type 2 diabetic patients in secondary failure: effects on glycaemic control and diet induced thermogenesis.
Topics: Acarbose; Biomarkers; Blood Glucose; Blood Pressure; Body Mass Index; Body Temperature Regulation; Diabetes Mellitus, Type 2; Eating; Energy Metabolism; Female; Fructosamine; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Male; Middle Aged; Postprandial Period; Regression Analysis; Respiration; Sulfonylurea Compounds; Treatment Failure; Triglycerides; Trisaccharides | 1998 |
Detection of structural alterations in LDL isolated from type 2 diabetic patients: application of the fructosamine assay to evaluate the extent of LDL glycation.
Topics: Adult; Aged; Aged, 80 and over; Diabetes Mellitus, Type 2; Female; Fructosamine; Glycosylation; Humans; Lipids; Lipoproteins, LDL; Male; Middle Aged | 1999 |
Economic evaluation of alternative indicators for screening for diabetes mellitus.
Topics: Adult; Aged; Aged, 80 and over; Cost-Benefit Analysis; Deoxyglucose; Diabetes Mellitus, Type 2; Fructosamine; Glucose Intolerance; Glycated Hemoglobin; Humans; Male; Mass Screening; Middle Aged; Models, Econometric; Sensitivity and Specificity | 1999 |
Relation with preoperative fructosamine and autonomic nerve function and blood pressure during anesthesia in diabetics: a retrospective study.
Topics: Aged; Anesthesia; Autonomic Nervous System; Blood Pressure; Diabetes Mellitus, Type 2; Fructosamine; Humans; Intraoperative Complications; Middle Aged; Retrospective Studies | 1999 |
Is glycation of low density lipoproteins in patients with Type 2 diabetes mellitus a LDL pre-oxidative condition?
Topics: Aged; Antibodies, Monoclonal; Apolipoproteins B; Biomarkers; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Diabetes Mellitus, Type 2; Enzyme-Linked Immunosorbent Assay; Female; Fructosamine; Glycated Hemoglobin; Glycation End Products, Advanced; Glycosylation; Humans; Lipoproteins, LDL; Male; Malondialdehyde; Middle Aged; Reference Values; Regression Analysis; Triglycerides; Vitamin E | 1999 |
Usefulness of fructosamine for monitoring outpatients with diabetes.
Topics: Blood Glucose; Case-Control Studies; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Fasting; Female; Fructosamine; Glycated Hemoglobin; Humans; Male; Office Visits; Predictive Value of Tests; Time Factors | 1999 |
No difference in serum sialic acid in type 2 diabetic patients from the United Arab Emirates with and without diabetic retinopathy.
Topics: Aged; Arabs; Asia; Biomarkers; Blood Pressure; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Europe; Female; Fructosamine; Humans; Male; Middle Aged; N-Acetylneuraminic Acid; United Arab Emirates | 2000 |
Can plasma fructosamine substitute for glycated haemoglobin (HbA1c) estimation in the assessment of diabetic control?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Case-Control Studies; Child; Child, Preschool; Diabetes Mellitus, Type 2; Female; Fructosamine; Glycated Hemoglobin; Humans; Male; Middle Aged; Reproducibility of Results; Sensitivity and Specificity; United Arab Emirates | 2000 |
Evaluation of the effect of performance monitoring and feedback on care process, utilization, and outcome.
Topics: Adolescent; Adult; Aged; California; Clinical Laboratory Techniques; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Drug Prescriptions; Female; Fructosamine; Glycated Hemoglobin; Health Maintenance Organizations; Hospitalization; Humans; Male; Middle Aged; Outpatients; Quality Assurance, Health Care | 2000 |
Evaluation of HbA1c determination methods in patients with hemoglobinopathies.
Topics: Biomarkers; Blood Chemical Analysis; Chromatography, High Pressure Liquid; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Fructosamine; Glycated Hemoglobin; Hemoglobinopathies; Hemoglobins, Abnormal; Humans | 2000 |
Onset and evolution of nephropathy in rats with spontaneous diabetes mellitus.
Topics: Animals; Blood Glucose; Body Weight; Creatinine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Disease Models, Animal; Disease Progression; Electrolytes; Fructosamine; Glomerular Filtration Rate; Glycosuria; Kidney; Kidney Glomerulus; Male; Pancreas; Proteinuria; Rats; Rats, Mutant Strains; Rats, Wistar; Urea | 2000 |
A sustained, non-insulin related, hypoglycaemic effect of electroacupuncture in diabetic Psammomys obesus.
Topics: Analysis of Variance; Animals; Blood Glucose; Cholesterol; Diabetes Mellitus, Type 2; Disease Models, Animal; Electroacupuncture; Fructosamine; Gerbillinae; Hypoglycemia; Insulin; Insulin Resistance; Male; Rats; Time Factors; Triglycerides | 2000 |
Diabetic control among NIDDM patients in urban and rural areas in Malaysia.
Topics: Body Mass Index; Diabetes Mellitus, Type 2; Fructosamine; Glycated Hemoglobin; Rural Health; Urban Health | 1996 |
Effect of aerobic training on diabetic nephropathy in a rat model of type 2 diabetes mellitus.
Topics: Albuminuria; Animals; Blood Glucose; Blood Pressure; Cholesterol; Creatinine; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Disease Models, Animal; Fructosamine; Glycated Hemoglobin; Insulin; Kidney; Kidney Glomerulus; Male; Obesity; Organ Size; Physical Conditioning, Animal; Rats; Rats, Zucker; Triglycerides | 2000 |
Fibronectin and lipoprotein(a) are inversely related to plasminogen activator inhibitor type-1 levels in Type 2 diabetic patients without complications.
Topics: Blood Glucose; Cholesterol; Diabetes Mellitus, Type 2; Female; Fibronectins; Fructosamine; Glycated Hemoglobin; Humans; Lipoprotein(a); Male; Middle Aged; Plasminogen Activator Inhibitor 1; Reference Values; Regression Analysis; Tissue Plasminogen Activator; Triglycerides | 2000 |
Effect of four-week metformin treatment on plasma and erythrocyte antioxidative defense enzymes in newly diagnosed obese patients with type 2 diabetes.
Topics: Blood Glucose; C-Peptide; Catalase; Diabetes Mellitus; Diabetes Mellitus, Type 2; Erythrocytes; Fructosamine; Glutathione; Glutathione Peroxidase; Humans; Hydrogen Peroxide; Hypoglycemic Agents; In Vitro Techniques; Lipid Peroxidation; Metformin; Middle Aged; Obesity; Oxidative Stress; Reference Values; Superoxide Dismutase | 2000 |
Multisite evaluation of a new diabetes self-test for glucose and glycated protein (fructosamine).
Topics: Adolescent; Adult; Aged; Biomarkers; Blood Glucose; Blood Glucose Self-Monitoring; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Fructosamine; Glycosylation; Humans; Hypoglycemic Agents; Male; Middle Aged; Monitoring, Ambulatory; Regression Analysis; Reproducibility of Results; Sensitivity and Specificity | 2000 |
Clinical validity of a self-test fructosamine in outpatient diabetic management.
Topics: Adult; Biomarkers; Blood Specimen Collection; Cross-Sectional Studies; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Fructosamine; Glycated Hemoglobin; Humans; Middle Aged; Monitoring, Ambulatory; Monitoring, Physiologic; Reference Values; Regression Analysis; Self Care; Time Factors | 1999 |
Oxidant and antioxidant systems in niddm patients: influence of vitamin E supplementation.
Topics: Adult; Antioxidants; Blood Glucose; C-Peptide; Cholesterol, HDL; Diabetes Mellitus, Type 2; Female; Fructosamine; Glutathione Peroxidase; Humans; Insulin; Lipid Peroxides; Lipids; Male; Middle Aged; Oxidative Stress; Sulfhydryl Compounds; Superoxide Dismutase; Thiobarbituric Acid Reactive Substances; Vitamin E | 2001 |
Can fructosamine be a surrogate for HbA(1c) in evaluating the achievement of therapeutic goals in diabetes?
Topics: Adult; Aged; Biomarkers; Blood Glucose; Body Mass Index; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Fasting; Female; Fructosamine; Glycated Hemoglobin; Humans; Male; Middle Aged; Reproducibility of Results | 2001 |
Parameters of glucose and lipid metabolism in the male Göttingen minipig: influence of age, body weight, and breeding family.
Topics: Aging; Animals; Blood Glucose; Body Weight; Breeding; C-Peptide; Diabetes Mellitus, Type 2; Disease Models, Animal; Fructosamine; Homeostasis; Humans; Insulin; Lipids; Male; Reference Values; Swine; Swine, Miniature; Triglycerides | 2001 |
Beneficial effects of hormonal replacement therapy on chromium status and glucose and lipid metabolism in postmenopausal women.
Topics: Administration, Oral; Blood Glucose; Cardiovascular Diseases; Cholesterol, LDL; Chromium; Dehydroepiandrosterone Sulfate; Diabetes Mellitus, Type 2; Drug Administration Schedule; Dydrogesterone; Estradiol; Estrogen Replacement Therapy; Female; Fructosamine; Humans; Hydrocortisone; Insulin; Leptin; Middle Aged; Postmenopause; Reference Values | 2002 |
Serum nickel levels of diabetic patients and healthy controls by AAS with a graphite furnace.
Topics: Adult; Aged; Aging; Blood Glucose; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Fructosamine; Hemoglobins; Hexosamines; Humans; Male; Middle Aged; N-Acetylneuraminic Acid; Nickel; Sialic Acids; Spectrophotometry, Atomic | 1992 |
White coat hyperglycaemia: disparity between diabetes clinic and home blood glucose concentrations.
Topics: Aged; Ambulatory Care; Aptitude; Blood Glucose; Blood Glucose Self-Monitoring; Diabetes Mellitus, Type 2; Fructosamine; Hexosamines; Humans; Hyperglycemia; Middle Aged; Observer Variation; Outpatient Clinics, Hospital; Prospective Studies; Random Allocation | 1992 |
The inter-relationships between albuminuria, plasma albumin concentration and indices of glycaemic control in non-insulin-dependent diabetes mellitus.
Topics: Adult; Aged; Albuminuria; Blood Glucose; Creatinine; Diabetes Mellitus, Type 2; Female; Fructosamine; Hexosamines; Humans; Male; Middle Aged; Serum Albumin | 1992 |
Measurement of glycated albumin by the nitroblue tetrazolium colorimetric method.
Topics: Chromatography, Affinity; Chromatography, High Pressure Liquid; Colorimetry; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Fructosamine; Globulins; Glycation End Products, Advanced; Hexosamines; Humans; Nitroblue Tetrazolium; Oxidation-Reduction; Polyethylene Glycols; Reference Values; Serum Albumin | 1992 |
Value of fasting blood glucose and serum fructosamine as a measure of diabetic control in non-insulin-dependent diabetes mellitus.
Topics: Adult; Aged; Aged, 80 and over; Blood Glucose; Diabetes Mellitus, Type 2; Fasting; Female; Fructosamine; Glycated Hemoglobin; Hexosamines; Humans; Male; Middle Aged; Monitoring, Physiologic; Predictive Value of Tests; Sensitivity and Specificity | 1992 |
Has the process causing noninsulin dependent diabetes start at birth? Evidence in neonates from a population with a high prevalence of diabetes.
Topics: Adult; Anthropometry; Birth Weight; Body Height; C-Peptide; Diabetes Mellitus, Type 2; Diabetes, Gestational; Ethnicity; Europe; Female; Fetal Blood; Fructosamine; Head; Hexosamines; Hospitals, Maternity; Hospitals, Public; Humans; Hyperinsulinism; Infant, Newborn; Insulin; New Zealand; Parity; Polynesia; Pregnancy; Prevalence; Risk Factors; Skinfold Thickness | 1992 |
Physiologic concentrations of inorganic phosphate accelerate fructosamine synthesis.
Topics: Adult; Blood Glucose; Diabetes Mellitus, Type 2; Fructosamine; Glucose Tolerance Test; Hexosamines; Humans; Kinetics; Phosphates; Reference Values; Time Factors | 1992 |
In vivo insulin action and muscle glycogen synthase activity in type 2 (non-insulin-dependent) diabetes mellitus: effects of diet treatment.
Topics: Aged; Biomarkers; Blood Glucose; Body Mass Index; C-Peptide; Calorimetry; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diet, Diabetic; Fatty Acids, Nonesterified; Female; Fructosamine; Glycogen Synthase; Hexosamines; Humans; Insulin; Male; Muscles; Obesity; Receptor, Insulin; Reference Values | 1992 |
Effects of slow release bezafibrate on the lipid pattern and on blood glucose of type 2 diabetic patients with hyperlipidaemia.
Topics: Aged; Bezafibrate; Blood Glucose; Cholesterol; Diabetes Mellitus, Type 2; Female; Fructosamine; Hemoglobins; Hexosamines; Humans; Hyperlipidemias; Lipids; Lipoproteins, HDL; Male; Middle Aged; Triglycerides | 1992 |
Increased in vivo production of tumor necrosis factor after development of diabetes in nontreated, long-term diabetic BB rats.
Topics: Age Factors; Animals; Blood Glucose; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Fructosamine; Hexosamines; Lipopolysaccharides; Male; Mice; Mice, Inbred Strains; Rats; Rats, Inbred BB; Rats, Inbred Strains; Serum Albumin; Tumor Necrosis Factor-alpha | 1992 |
Fructosamine measurement.
Topics: Biomarkers; Blood Glucose; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Fructosamine; Hexosamines; Humans; Reagent Kits, Diagnostic | 1992 |
Comparisons of home blood glucose testing and glycated protein measurements.
Topics: Adolescent; Adult; Analysis of Variance; Biomarkers; Blood Glucose Self-Monitoring; Blood Proteins; Child; Chromatography, High Pressure Liquid; Diabetes Mellitus, Type 2; Female; Fructosamine; Glycated Hemoglobin; Glycated Serum Proteins; Glycoproteins; Glycosylation; Hexosamines; Humans; Male; Probability | 1992 |
Beneficial effect of a low glycaemic index diet in type 2 diabetes.
Topics: Aged; Biomarkers; Blood Glucose; C-Peptide; Cholesterol; Creatinine; Diabetes Mellitus, Type 2; Diet, Diabetic; Dietary Carbohydrates; Energy Intake; Female; Fructosamine; Glyburide; Hexosamines; Humans; Insulin; Male; Triglycerides; Urea | 1992 |
[Care for the diabetic patient in Catalonia. A study of a population sample].
Topics: Age Factors; Blood Glucose Self-Monitoring; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Fructosamine; Glycated Hemoglobin; Hexosamines; Humans; Patient Care Planning; Quality of Health Care; Risk Factors; Sex Factors; Spain; Surveys and Questionnaires | 1992 |
Comparison of serum fructosamine and blood glucose concentrations as indices of glycaemic control in non-insulin dependent diabetic out-patients.
Topics: Adult; Blood Glucose; Diabetes Mellitus, Type 2; Female; Fructosamine; Hexosamines; Humans; Male; Middle Aged | 1992 |
Glycated proteins in elderly type II diabetic patients: role of age and serum protein concentration.
Topics: Age Factors; Aged; Aged, 80 and over; Blood Glucose; Blood Proteins; Diabetes Mellitus, Type 2; Female; Fructosamine; Glycated Hemoglobin; Hexosamines; Humans; Male | 1991 |
Serum ketone response to glucagon as a marker of insulin dependency in diabetics.
Topics: 3-Hydroxybutyric Acid; Acetoacetates; Adult; Biomarkers; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Fatty Acids, Nonesterified; Female; Fructosamine; Glucagon; Hexosamines; Humans; Hydroxybutyrates; Ketone Bodies; Kinetics; Male; Middle Aged; Regression Analysis | 1991 |
Correction of fructosamine value for serum albumin and globulin concentrations.
Topics: Diabetes Mellitus, Type 2; Female; Fructosamine; Glycated Hemoglobin; Hexosamines; Humans; Male; Middle Aged; Serum Albumin; Serum Globulins | 1991 |
Abnormal serum immunoglobulin concentrations in patients with diabetes mellitus.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aging; Child; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Fructosamine; Hexosamines; Humans; Immunoglobulin A; Immunoglobulin G; Immunoglobulin M; Immunoglobulins; Male; Middle Aged | 1991 |
Lipoprotein lipids and apolipoproteins (AI, AII, B, CII, CIII) in type 1 and type 2 diabetes mellitus in young Kuwaiti women.
Topics: Adolescent; Adult; Age Factors; Apolipoproteins; Biomarkers; Blood Glucose; Body Mass Index; Cardiovascular Diseases; Cholesterol; Cholesterol, LDL; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Fructosamine; Glycated Hemoglobin; Hexosamines; Humans; Kuwait; Lipids; Lipoproteins; Risk Factors; Triglycerides | 1991 |
Relation of lipid peroxides to macrovascular disease in type 2 diabetes.
Topics: Adult; Aged; Apolipoproteins; Arteriosclerosis; Blood Coagulation Factors; Blood Glucose; Cholesterol; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Fructosamine; Glycated Hemoglobin; Hexosamines; Humans; Lipid Peroxides; Lipids; Lipoproteins; Lipoproteins, HDL; Male; Middle Aged; Multivariate Analysis; Regression Analysis; Triglycerides | 1991 |
Disturbed handling of ascorbic acid in diabetic patients with and without microangiopathy during high dose ascorbate supplementation.
Topics: Administration, Oral; Aged; Ascorbic Acid; Blood Glucose; Dehydroascorbic Acid; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Retinopathy; Female; Fructosamine; Hexosamines; Humans; Male; Reference Values | 1991 |
Screening for hyperlipidaemia in diabetes mellitus. Relationship to glycaemic control.
Topics: Adolescent; Adult; Aged; Blood Glucose; Body Mass Index; Cholesterol; Cholesterol, HDL; Diabetes Complications; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Fructosamine; Glycated Hemoglobin; Hexosamines; Humans; Hypercholesterolemia; Hyperlipidemias; Hypertriglyceridemia; Male; Middle Aged; Triglycerides | 1991 |
Comparison of reliability of plasma fructosamine and glycosylated hemoglobin assays for assessing glycemic control in diabetic patients on hemodialysis.
Topics: Blood Glucose; Chromatography, Affinity; Diabetes Mellitus, Type 2; Fructosamine; Glycated Hemoglobin; Hexosamines; Humans; Middle Aged; Renal Dialysis | 1991 |
Serum fructosamine/haemoglobin A1 ratio predicts the future changes in haemoglobin A1 in type 2 (non-insulin dependent) diabetic patients.
Topics: Adult; Aged; Blood Glucose; Diabetes Mellitus, Type 2; Female; Fructosamine; Glycated Hemoglobin; Hexosamines; Humans; Male; Middle Aged; Predictive Value of Tests; Serum Albumin | 1991 |
[Some problems in standardization of fructosamine tests].
Topics: Adult; Aged; Biomarkers; Blood Proteins; Colorimetry; Diabetes Mellitus, Type 2; Female; Fructosamine; Glycated Serum Proteins; Glycoproteins; Glycosylation; Hexosamines; Humans; Male; Middle Aged; Reference Standards; Reference Values; Regression Analysis | 1991 |
Comparison of fructosamine with glycated hemoglobin as an index of glycemic control in diabetic patients.
Topics: Adult; Biomarkers; Blood Glucose; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Eating; Female; Fructosamine; Glucose; Glycated Hemoglobin; Hexosamines; Humans; Hypoglycemic Agents; Longitudinal Studies; Male; Middle Aged; Reference Values | 1990 |
Free radical activity in type 2 diabetes.
Topics: Blood Glucose; Ceruloplasmin; Diabetes Mellitus, Type 2; Erythrocytes; Female; Free Radicals; Fructosamine; Glycated Hemoglobin; Hemolysis; Hexosamines; Humans; Male; Middle Aged; Reference Values; Sulfhydryl Compounds; Superoxide Dismutase | 1990 |
Elevated plasma endothelin in patients with diabetes mellitus.
Topics: Adult; Blood Glucose; Creatinine; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Endothelins; Endothelium, Vascular; Female; Fructosamine; Hexosamines; Humans; Male; Middle Aged; Peptides; Reference Values | 1990 |
Automated fructosamine assay with improved accuracy used to quantify nonenzymatic glycation of serum proteins in diabetes mellitus and chronic renal failure.
Topics: Adult; Autoanalysis; Azo Compounds; Blood Glucose; Blood Proteins; Child; Detergents; Diabetes Mellitus, Type 2; False Positive Reactions; Female; Fructosamine; Glycosylation; Hexosamines; Humans; Kidney Failure, Chronic; Male; Serum Albumin; Uric Acid | 1990 |
[Routine control of type 2 diabetes. Are glycosylated hemoglobin and fructosamine measurements necessary?].
Topics: Adult; Aged; Blood Glucose; Diabetes Mellitus, Type 2; Diagnostic Tests, Routine; Fructosamine; Glycated Hemoglobin; Hexosamines; Humans; Middle Aged | 1990 |
Effects of low dose guar in non-insulin dependent diabetic patients.
Topics: Adult; Aged; Blood Glucose; Body Weight; Cholesterol; Chromatography, High Pressure Liquid; Diabetes Mellitus, Type 2; Fasting; Female; Fructosamine; Galactans; Glycated Hemoglobin; Hexosamines; Humans; Male; Mannans; Middle Aged; Plant Gums; Triglycerides | 1990 |
Unique aspects of diabetes mellitus in the elderly.
Topics: Age Factors; Aged; Diabetes Mellitus, Type 2; Fructosamine; Glycated Hemoglobin; Hexosamines; Humans | 1990 |
Factors associated with development of diabetes mellitus: results from a cross sectional survey in Kawerau.
Topics: Alcohol Drinking; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Fructosamine; Hexosamines; Humans; Hyperinsulinism; Hypertension; Hypertriglyceridemia; Life Style; Middle Aged; New Zealand; Risk Factors; Rural Health | 1990 |
[The effect of hyperlipoproteinemia on serum fructosamine].
Topics: Blood Proteins; Cholesterol; Cholesterol, HDL; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Fructosamine; Glycated Hemoglobin; Hexosamines; Humans; Hyperlipoproteinemias; Serum Albumin; Triglycerides | 1990 |
[Fructosamine values in venous and capillary blood].
Topics: Blood Specimen Collection; Capillary Permeability; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Fructosamine; Glycated Hemoglobin; Hexosamines; Humans | 1990 |
[Effect of a change in posture on the diurnal variations of fructosamine concentration in diabetic patients].
Topics: Adolescent; Adult; Blood Glucose; Blood Proteins; Circadian Rhythm; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Fructosamine; Glycated Hemoglobin; Hexosamines; Humans; Male; Middle Aged; Posture | 1990 |
Performance and clinical significance of the new fructosamine assay in diabetic patients.
Topics: Adult; Aged; Aged, 80 and over; Blood Proteins; Cholesterol; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Fructosamine; Glycated Hemoglobin; Hexosamines; Humans; Male; Middle Aged; Nitroblue Tetrazolium; Triglycerides | 1990 |
[Diagnosis of the diabetic metabolic status using fructosamine (and HbA1c) determination. The glycation quotient Glyc-Q, the glycation nomogram].
Topics: Blood Glucose; Blood Proteins; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Fructosamine; Glycated Hemoglobin; Glycated Serum Proteins; Glycoproteins; Hexosamines; Humans; Reference Values | 1990 |
[Diurnal variations of fructosamine in patients with type II diabetes mellitus].
Topics: Adult; Blood Glucose; Blood Proteins; Circadian Rhythm; Creatinine; Diabetes Mellitus, Type 2; Female; Fructosamine; Glycated Hemoglobin; Hexosamines; Humans; Male; Serum Albumin | 1990 |
[Comparison of HbA1c, fructosamine and the main metabolic parameters in a non-insulin-dependent diabetic population].
Topics: Aged; Blood Glucose; Cholesterol; Cholesterol, LDL; Diabetes Mellitus, Type 2; Female; Fructosamine; Glycated Hemoglobin; Hexosamines; Humans; Male; Triglycerides | 1990 |
Effect of 75 g oral glucose on fructosamine and glycated haemoglobin concentrations.
Topics: Adult; Aged; Diabetes Mellitus, Type 2; Fasting; Female; Fructosamine; Glucose; Glycated Hemoglobin; Hexosamines; Humans; Male; Middle Aged | 1990 |
The clinical usefulness of serum fructosamine and HbAlc in patients with NIDDM.
Topics: Adult; Aged; Blood Glucose; Diabetes Mellitus, Type 2; Environmental Monitoring; Female; Fructosamine; Glycated Hemoglobin; Hexosamines; Humans; Male; Middle Aged | 1989 |
Lipoprotein subfraction composition in non-obese newly diagnosed non-insulin dependent diabetes after treatment with diet and glibenclamide.
Topics: Alcohol Drinking; Apolipoproteins; Blood Glucose; Blood Pressure; Body Mass Index; Cholesterol; Diabetes Mellitus, Type 2; Diet, Diabetic; Female; Fructosamine; Glyburide; Glycated Hemoglobin; Hexosamines; Humans; Insulin; Lipoproteins; Male; Middle Aged; Reference Values; Smoking; Triglycerides | 1989 |
Clinical utility of assays of glycosylated haemoglobin and serum fructosamine compared: use of data on biological variation.
Topics: Aged; Aged, 80 and over; Biomarkers; Diabetes Mellitus, Type 2; Female; Fructosamine; Glycated Hemoglobin; Hexosamines; Humans; Male; Middle Aged; Time Factors | 1989 |
[Determination of fasting blood glucose and serum fructosamine levels for the assessment of glucose regulation in patients with non-insulin dependent diabetes mellitus].
Topics: Blood Glucose; Diabetes Mellitus, Type 2; Fructosamine; Glycated Hemoglobin; Hexosamines; Humans; Predictive Value of Tests; Reference Values | 1989 |
Serum fructosamine in assessment of diabetic control and relation to thyroid function.
Topics: Adult; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Fructosamine; Hexosamines; Humans; Hyperthyroidism; Hypothyroidism; Male; Middle Aged | 1989 |
[2,070 simultaneous determinations of blood glucose, glucosylated hemoglobin and fructosamine as index of metabolic control in 519 diabetic patients].
Topics: Adolescent; Adult; Aged; Blood Glucose; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Follow-Up Studies; Fructosamine; Glycated Hemoglobin; Hexosamines; Humans; Longitudinal Studies; Male; Middle Aged; Retrospective Studies | 1989 |
Platelet function in patients with type 2 diabetes mellitus: the effect of glycaemic control.
Topics: Adult; Apolipoproteins; Biomarkers; Blood Glucose; Blood Platelets; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Female; Fructosamine; Glycated Hemoglobin; Hexosamines; Humans; In Vitro Techniques; Insulin; Lipoproteins, HDL; Male; Middle Aged; Platelet Aggregation; Thromboxane B2 | 1989 |
[Value of the determination of glycosylated proteins and glycosylated hemoglobin in therapy control of diabetic patients].
Topics: Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Follow-Up Studies; Fructosamine; Glycated Hemoglobin; Hexosamines; Humans | 1989 |
[Critical evaluation of fructosamine as a control parameter in the assessment of diabetic metabolic regulation].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Blood Glucose; Blood Proteins; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Fructosamine; Glycated Hemoglobin; Hexosamines; Humans; Male; Middle Aged | 1989 |
[Fructosamine and glycosylated hemoglobin as parameters of hyperglycemia].
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Fructosamine; Glycated Hemoglobin; Hexosamines; Humans; Hyperglycemia; Middle Aged | 1989 |
[Levels of fasting blood glucose and serum fructosamine for monitoring of glucose control in patients with non-insulin-dependent diabetes mellitus].
Topics: Adult; Aged; Aged, 80 and over; Blood Glucose; Diabetes Mellitus, Type 2; Female; Fructosamine; Glycated Hemoglobin; Hexosamines; Humans; Male; Middle Aged; Predictive Value of Tests | 1989 |
Is serum fructosamine a clinically useful test?
Topics: Blood Proteins; Diabetes Mellitus, Type 2; Drug Evaluation; Female; Fructosamine; Glycated Hemoglobin; Hematologic Diseases; Hexosamines; Humans; Male; Methods; Pregnancy; Pregnancy in Diabetics | 1988 |
Is serum fructosamine assay specific for determination of glycated serum protein?
Topics: Blood Proteins; Borohydrides; Diabetes Mellitus, Type 2; Fructosamine; Glycated Hemoglobin; Glycated Serum Albumin; Glycated Serum Proteins; Glycation End Products, Advanced; Glycoproteins; Glycosylation; Hexosamines; Humans; Lysine; Serum Albumin | 1988 |
Effect of gliclazide on thromboxane B2, parameters of haemostasis, fluorescent IgG and lipid peroxides in non-insulin dependent diabetes mellitus.
Topics: Aged; Blood Proteins; Diabetes Mellitus, Type 2; Female; Fructosamine; Gliclazide; Glyburide; Glycated Hemoglobin; Hexosamines; Humans; Immunoglobulin G; Lipid Peroxides; Male; Platelet Aggregation; Sulfonylurea Compounds; Thromboxane B2 | 1988 |
[Variation of the fructosamine test in the determination of the concentration of nonenzymatic glucose bound to serum proteins by reference to the protein concentration and the use of a protein standard].
Topics: Blood Glucose; Blood Proteins; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Fructosamine; Hexosamines; Humans; Reference Standards | 1988 |
Validity of serum fructosamine as index of short-term glycemic control in diabetic outpatients.
Topics: Biomarkers; Blood Glucose; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Fructosamine; Glycated Hemoglobin; Hexosamines; Humans; Monitoring, Physiologic | 1988 |
Long-term performance of the fructosamine assay.
Topics: Adult; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Fructosamine; Glycated Hemoglobin; Hexosamines; Humans; Male; Quality Control; Reference Values; ROC Curve | 1988 |
Effect of nifedipine on glucose tolerance, serum insulin, and serum fructosamine in diabetic and nondiabetic patients.
Topics: Blood Glucose; Diabetes Mellitus, Type 2; Female; Fructosamine; Glucose Tolerance Test; Hexosamines; Humans; Hypertension; Insulin; Male; Middle Aged; Nifedipine | 1987 |
[Fructosamine determination as a screening test for diabetes mellitus in patients with acute coronary heart disease].
Topics: Coronary Disease; Diabetes Mellitus, Type 2; Fructosamine; Glucose Tolerance Test; Glycated Hemoglobin; Hexosamines; Humans; Myocardial Infarction | 1988 |
Fructosamine assay: an index of medium-term metabolic control parameters in diabetic disease.
Topics: Adolescent; Adult; Aged; Blood Glucose; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Fructosamine; Glycated Hemoglobin; Hexosamines; Humans; Male; Middle Aged | 1988 |
Comparison of fructosamine with glycosylated hemoglobin and plasma proteins as measures of glycemic control.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Blood Proteins; Clinical Laboratory Techniques; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Fructosamine; Glycated Hemoglobin; Glycated Serum Proteins; Glycoproteins; Glycosylation; Hexosamines; Humans; Middle Aged | 1988 |
The management of diabetes in general practice.
Topics: Aged; Diabetes Mellitus, Type 2; Family Practice; Female; Fructosamine; Hexosamines; Humans; Male; Medical Audit; Middle Aged; New Zealand; Prospective Studies; Referral and Consultation | 1988 |
Assessment of past glycemic control. Measure fructosamine, hemoglobin A1, or both?
Topics: Blood Proteins; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Fructosamine; Glycated Hemoglobin; Glycosylation; Hexosamines; Humans | 1988 |
Serum fructosamine level as a marker of glycemic control in diabetic patients with and without a residual C-peptide secretion.
Topics: Blood Glucose; C-Peptide; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Fructosamine; Glycated Hemoglobin; Hexosamines; Humans | 1987 |
Vitamin C metabolites and microangiopathy in diabetes mellitus.
Topics: Ascorbic Acid; Dehydroascorbic Acid; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Retinopathy; Fructosamine; Hexosamines; Humans; Middle Aged; Reference Values | 1987 |
Fructosamine in a diabetic clinic.
Topics: Adolescent; Adult; Aged; Blood Glucose; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Fructosamine; Hexosamines; Humans; Middle Aged; New Zealand; Outpatient Clinics, Hospital; Serum Albumin | 1987 |
Plasma protein glycation as measured by fructosamine assay.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Blood Glucose; Blood Proteins; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Fructosamine; Glucose Tolerance Test; Glycated Hemoglobin; Glycosylation; Hexosamines; Humans; Male; Middle Aged; Quality Control | 1987 |
Serum fructosamine in patients with diabetes mellitus.
Topics: Adolescent; Adult; Aged; Blood Glucose; Cholesterol; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Fructosamine; Glycated Hemoglobin; Hexosamines; Humans; Male; Middle Aged; Monitoring, Physiologic; Triglycerides | 1985 |
Goals and assessment of diabetic control.
Topics: Blood Glucose; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Fructosamine; Glycated Hemoglobin; Hexosamines; Humans; Insulin; Monitoring, Physiologic | 1985 |
Improved estimation of fructosamine, as a measure of glycated serum protein, with the Technicon RA-1000 analyzer.
Topics: Autoanalysis; Blood Proteins; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Fructosamine; Glycated Hemoglobin; Glycated Serum Proteins; Glycoproteins; Hexosamines; Humans; Male; Reference Values | 1985 |
[Practical value of serum fructosamine determination in diabetes mellitus].
Topics: Adolescent; Adult; Aged; Blood Glucose; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dietary Carbohydrates; Female; Fructosamine; Glycated Hemoglobin; Glycosuria; Hexosamines; Humans; Male; Middle Aged | 1985 |